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INTRODUCTION 
The regulation of maternal and zygotic gene expression in Drosophila is 
required for early pattern formation in the embryo. The embryonic polarity along 
the anterior-posterior and dorsal-ventral axes of the egg is established through the 
activity of maternal gene products that accumulate during oogenesis. This activity 
allows the establishment of specialized domains of zygotic gene expression 
(Konrad et at, 1985; Mahowald and Hardy, 1985; Akam, 1987; Anderson, 1987; 
Niisslein-Volhard et ah, 1987; Ingham, 1988). 
The Torso Signaling Pathway 
It has been shown that three maternal groups of genes are required for the 
establishment of the anterior-posterior axis (Niisslein-Volhard et ah, 1987; 
Niisslein-Volhard, 1991; St. Johnston and Niisslein-Volhard, 1992). Patterrung in 
the head and thoracic regions is controlled by a morphogenic gradient of the hicoid 
protein (Driever and Niisslein-Volhard, 1988a, 1988b). Patterrung in the abdominal 
regions is controlled by a morphogenic gradient of the nanos protein (Wang and 
Lehmarm, 1991). The last group is the terminal class genes and they are required 
for the development of the head (acron) and tail (telson) (Niisslein-Volhard et ah, 
1987; St. Johnston and Niisslein-Volhard, 1992). The maternally active members in 
this class have been identified. These include: fs(l)Nasrat (Degelmarm et ah, 1986), 
fsWpolehole (Perrimon et ah, 1986), fs(3)torso-like (Stevens et ah, 1990), fs(2)trunk, 
fs(2)torso (Schupbach and Wieschaus, 1986), Drk (Olivier et ah, 1993; Simon et ah, 
1993), Sos (Buday and Downward, 1993), D-rasl (Lu et ah, 1993), D-ra/[also known 
as KDpolehole] (Perrimon et ah, 1985; Nishida et ah, 1988), D-MEK [also known as 
Dsor] (Tsuda et ah, 1993), DmErk [also known as rolled] (Biggs ni and Spursky, 
1992), and corkscrew (Perkins et ah, 1992). 
The maternal terminal genes function to activate the expression of the zygotic 
genes, tailless (Strecker et ah, 1986,1988) and huckebein (Weigel et ah, 1990). These 
zygotic genes encode putative transcription factors that are expressed in limited 
regions of embryoruc poles. They are required for the subsequent development of 
the terminal structures (Pignoni et ah, 1990; Brormer and Jackie, 1991). Loss-of-
function (1-o-f) of the maternal terminal gene products produced by the female 
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germline results in the deletion of anterior and posterior embryoruc terminal 
structures in the embryo. Thus, in the absence of these gene products the anterior 
head skeleton is trimcated and all structures posterior to the seventh abdominal 
segment are missing, including the Filzkorper. An exception to this is corkscrew. In 
the absence of the maternal corkscrew gene product, only the posterior endodermal 
derivatives are deleted and corkscrew embryos develop Filzkorper (Perkins et ah, 
1992). 
A majority of the maternal terminal genes have been cloned and characterized. 
These gene products participate in a signal transduction pathway that is activated 
by the receptor tyrosine kinase torso (Casanova and Struhl, 1989; Sprenger et ah, 
1989), and the signal is mediated through the following cytoplasmic gene products: 
Drk encodes a SH3-SH2-SH3 protein that couples the receptor tyrosine kinase to 
Sos (Olivier et ah, 1993; Simon et al, 1993); Sos encodes a guanine nucleotide 
exchange factor for Ras 1 (Buday and Downward, 1993); Ras 1 is homologous to 
mammalian Ki/Ha ras (p21'^3S) (Lu gi al, 1993), which recruits Raf-1 kinase to the 
plasma membrane (Leevers et al, 1994; Stokoe et al, 1994); D-raf gene encodes a 
serine/threonine kinase that is homologous to the mammalian raf-1 proto-
oncogene product (Mark et al, 1987; Nishida et al, 1988); Dsor encodes a putative 
protein kinase similar to the mitogen-activated protein (MAP) kinase activator 
(Tsuda et al, 1993); DmErfc encodes a functional homolog of a rat extracellular 
signal-regulated kinase (ERK), also known as the mitogen-activated protein (MAP) 
kinase (Biggs HI and Zipursky, 1992). Finally, corkscrew encodes a putative non­
receptor protein tyrosine phosphatase homologous to the mammalian PTPIC 
protein. This protein presumably acts to regulate the level of the torso signal 
(Perkins et al, 1992). A model for the Torso-mediated signal transduction is shown 
in Figure 1. 
Structure and Function of D-raf 
D-raf gene has been cloned (Nishida et al, 1988) and encodes the three 
conserved regior\s (CRl, CR2, and CR3) which are a common characteristic of the 
raf protein kinase family. The function of D-raf in the terminal class signal 
transduction pathway is similar to that of Raf-1 during the proliferation of 
mammalian cells. Raf-1 functions as a signal transducer for extracellular growth 
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Figure 1. Model for Torso signal transduction pathway. 
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factors and acts downstream of the receptor tyrosine kinase. Activation of the 
receptor results in the hyperphosphorylation of Raf-1 and stimulation of its 
serine/threonine kinase activity (Morrison et al, 1988). In addition, it has shown 
that activated Raf-1 protein can act as an intermediate to regulate the transcription 
of the c-fos and actin genes (Kaibuchi et al, 1989; Wasylyk et al, 1989; Jamal and 
Ziff, 1990). Recent biochemical studies have shown that D-raf has intrinsic 
serine/threonine kinase activity (Sprenger et al, 1993). Therefore, it is likely that 
D-raf, as a serine/threorune kinase, acts to transduce the terminal signal to activate 
the expression of tailless and huckebein. 
At the amino acid level, there is 45% homology between D-raf and the 
mammalian Raf-1 with 65% identity in the serine/threonine kinase domain (Mark 
et al, 1987; Nishida et al, 1988). Primary amino acid analysis suggests that Raf-1 
contains an N-terminal regulatory region and a carboxy-terminal catalytic region 
contairiing the kinase domain (CR3) (Bormer et al, 1986; Beck et al, 1987; Rapp et 
al, 1988). The mechanism by which the N-terminal region of Raf-1 regulates the 
molecule is not known, but it contains a cysteine rich region (CRl) and a 
serine/threonine rich domain (CR2) (Rapp et al, 1988). Recent research showed 
that Ras binds the CRl domain of Raf-1 (Moodie et al, 1993; Van Aelst et al, 1993; 
Vojtek et al, 1993; Warne et al, 1993; Zhang et al, 1993) and recruits Raf-1 to the 
plasma membrane (Leevers et al, 1994; Stokoe et al, 1994). Removal of amino-
terminal sequences results in the transforming activation of Raf-1, indicating the 
role of the amino-terminal region in the negative regulation of Raf-1 (Bormer et al, 
1985). Also, the oncogenic v-raf protein is an amino-terminal truncation of the Raf-
1 protein. 
Regulation of Serine/Threonine Kinases 
Protein kinases and phosphatases have been shown to play a critical role as 
mediators in signal transduction pathways. Protein kinases trarisfer the terminal 
phosphate group of ATP to a serine, threonine, or tyrosine residue of substrate 
proteins. Protein phosphatases dephosphorylate on a serine, threonine or tyrosine 
residue. Thus, reversible protein phosphorylation is a useful mechanism by which 
the regulation of cell fate choices can be made. 
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All protein kinases can be categorized into two general classes : serine/ 
threonine-specific and tyrosine-specific. These kinases contain similar catalytic 
domains that have a highly conserved primary structure. The catalytic domain 
contains approximately 260 amino acid residues, corresponding to a molecular 
weight of 30 kDa (Hanks et ah, 1988; Taylor et ah, 1992). Eleven major conserved 
subdomains within the catalytic domain have been identified. It has been shown 
that these conserved subdomains function directly as components of the active site 
or indirectly by the formation of the active site. Interestingly, each class of kinases 
has certain specific short amino acid stretches. These sequences can be used to 
identify whether the kinase is tyrosine- or serine/threonine-specific (Hanks et ah, 
1988). 
The biochemical studies in mammalian cells as well as in Drosophila have 
shown that the phosphorylation of Raf-l and D-ra/kinases occurs on serine and 
threonine residues by the activation of a receptor tyrosine kinase, suggesting that 
phosphorylation on serine and threonine residues is required for the signal 
transduction process (Morrison et ah, 1988; Sprenger et ah, 1993). By microinjecting 
mRNAs encoding various kinds of mutant Raf kinase, we address the role of D-raf 
in terminal class signal transduction pathway in Drosophila. 
Dissertation Organization 
This dissertation presents studies of D-raf in the terminal class signal 
transduction pathway. The three numbered chapters represent journal 
manuscripts. The chapters are followed by a general summary. The references 
cited in the general introduction are listed following the general summary. 
Chapter 1 reports the development of a microinjection technique for Drosophila 
embryos. The work has been published in BioTechniques (Baek, K.-H., and 
Ambrosio, L. BioTechniques 17:1024-1026,1994). 
Chapter 2 presents the requirement of D-raf association with the membrane 
and this is independent of activation of Torso receptor tyrosine kinase at the 
embryonic poles. My contribution included all the microinjection data and 
cuticular preparations. This work is the basis of a manuscript in preparation. 
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Chapter 3 deals with the temporal expression and dominant negative effects of 
D-raf. My contribution included all the microinjection data and cuticular 
preparations. This work is the basis of a manuscript in preparation. 
7 
CHAPTER 1: AN EFFICIENT METHOD FOR MICROINJECTION 
OF mRNA INTO DROSOPHILA EMBRYOS 
A paper published in BioTechniques^ 
Kwang-Hyun Baek* and Linda Ambrosio 
BACKGROUND 
Microinjection of nucleic acids into embryos is commonly used to (i) determine 
gene identity (4), (ii) assay the effect of mutation upon gene function (5), (iii) 
identify genes that are expressed in stage- and/or tissue-specific patterns (2), and 
(iv) eliminate gene function (6). Here we describe an efficient protocol using both 
air and vacuum systems to maximize embryonic viability after microinjection. The 
key element of this procedure is the removal of cytoplasm that often leaks from 
Drosophila embryos after microinjection. We show that removal of this leaked 
cytoplasm leads to a sigruficant increase in the percent of viable embryos. As a 
control experiment, nuclease-free distilled water was injected into embryos to 
determine their hatching rate after leaked cytoplasm was removed. We then tested 
this method after injection of D-raf mRNA into embryos lacking maternal D-raf 
protein. In both experiments a 40% increase in the number of embryos that 
completed development was observed. 
Injection Procedure 
Embryos were collected on molasses agar plates for 30 min and washed into a 
small basket. For basket construction, the bottom of a plastic scintillation vial was 
removed and a hole drilled into its cap, which was used to secure a 3 cm2 lO-^im-
mesh nylon screen (Spectrum Medical Industries, Houston, TX, USA). Chorions 
were removed by submerging the embryos into a bleach solution (50% Clorox®) 
^Reprinted with permission from BioTechniques 1994,17,1024-1026. Copyright © 1994 Eaton 
Publishing Company. 
*Author for correspondence. 
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for 3-5 min. The basket of embryos was rmsed thoroughly in a gentle stream of 
distilled water. Using forceps or a fine paint brush, 40-60 embryos were placed 
onto a patch of agar and then positioned to form a line with each embryo oriented 
in the same direction and not touching one another. The embryos were then 
transferred to the edge of a coverslip that had been streaked with a 400-fxm-wide 
line of glue using the tip of a Pasteur pipet. Embryos were placed approximately 
10-20 |im from the edge of the coverslip by gently touching them to the dried strip 
of glue. The glue was prepared by extracting pieces of brown packing tape with 
heptane overnight. For posterior injections, the posterior poles of the embryos 
were oriented towards the edge of the coverslip. To complete their preparation for 
injection, embryos were desiccated in a sealed jar containing Drierite^"*^ for various 
times depending upon their genotype. Typically, they were dried 8-12 min 
(Optimal desiccation is achieved when the embryonic surface indents slightly 
beneath the needle during microinjection). After desiccation, the embryos were 
covered with a thin layer of Halocarbon oil (Series 95; Halocarbon Products, North 
Augusta, SC, USA). 
Microinjections were performed using air (30 psi) and vacuum (700 mmHg) 
lines provided in house. A glass capillary needle was cormected to a needle holder 
attached at an angle of 8°-10° to a micromarupulator (Model M-152; Narishige, 
Tokyo, Japan) that was moimted on an inverted microscope stage (Model CK2; 
Olympus, Lake Success, NY, USA). The needle holder was joined by Tygon^" 
tubing to a 3-way valve that was connected to air and vacuimi systems. A second 
3-way valve was inserted between the air/vacuum line and the needle. This valve 
was left open and regulated by placing a finger over its opening (Figure 1). For 
injection, each embryo was pierced by moving the stage toward the glass needle. 
The tip of the needle was positioned within the embryo at 5%-10% egg length 
(posterior pole = 0%) by moving the stage away from it. A volvime approximately 
equal to 2%-5% of the embryo's total volimie was injected using air pressure, and 
the needle was quickly withdrawn (slow removal of the needle leads to an increase 
of embryos with leaked cytoplasm). Wrinkled embryos were avoided. After the 
completion of a set of microinjections, embryonic cytoplasm that had leaked was 
removed by vacuuming, using a second large diameter glass capillary attached to 
the house vacuum line. An additional round of removal was carried out when 
needed. For mRNA injections, the tip of the needle containing mRNAs was kept 
9 
under oil when not in use. Occasionally, this tip became clogged with vitelline 
membrane residue and was reopened by touching its apex to the edge of the 
coverslip containing the embryos. After microinjection, embryos were kept on the 
coverslip under oil in a 3% agar petri dish and incubated at 19°C and 80% 
humidity for 24-48 h. Prior to use, the agar in the petri dish was moderately dried 
to prevent the oil from spreading. Additional oil can be added to keep embryos 
submerged, but care must be taken so that the oil does not leak under the 
coverslip. Important factors that influence the viability of microinjected embryos 
are listed in Table 1. 
Needles were pulled from capillaries (o.d. 1.0 mm, i.d. 0.5 mm; World Precision 
Instruments, Sarasota, FL, USA) using a Vertical Pipette Puller (Model 700C; David 
Kopf Instruments, Pasadena, CA, USA). Sharp tips (a diameter of less than 6 |xm) 
were generated by touching the apex of the needle to the debris of broken 
coverslips that had been placed on a glass slide and partially embedded under 
double-sided tape. The glass needle was back-filled using a heat-pulled Pasteur 
pipet. A second glass capillary with a diameter greater than 40 |xm was made for 
vacuuming leaked cytoplasm. 
For in vitro transcription, the template plasmid (pGEM7 [Promega, Madison, 
WI, USA] + D-raf cDNA) was purified using the Plasmid Midi Kit from Qiagen 
(Chatsworth, CA, USA). The DNAs were linearized, extracted with phenol (pH 
7.4), precipitated with 0.1 vol of 3 M sodium acetate and 1.5 vol of ethanol and then 
dissolved in diethylpyrocarbonate (DEPC)-treated distilled water. mRNAs were 
generated using the mMESSAGE mMACHINE^" SP6 RNA Polymerase Kit from 
Ambion (Austin, TX, USA), and then dissolved in nuclease-free distilled water at 
1.0 ^lg/^il. 
D-rafmRNA Rescue 
We first determined the percent embryonic survival (as assayed by cuticle 
formation) after removal of leaked cytoplasm for wild-type embryos injected with 
nuclease-free distilled water. As shown in Table 2, when leaked cytoplasm was 
removed, embryonic viability increased from 34% to 74%. In this experiment 
approximately 70%-80% of the embryos leaked cytoplasm. For the dechorionated 
but uninjected control embryos, 87% viability was observed. In a second 
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experiment, after injection of in vitro synthesized wild-type D-raf mRNA into 
embryos that lack maternal D-raf activity, the number of embryos that completed 
development was 40% higher when leaked cytoplasm was removed, as shown in 
Table 3. Embryonic viability was increased from 59% to 99%. The percentage of 
embryoruc viability for uninjected embryos was 97% in this experiment. Maternal 
D-raf gene product is required for the determination of embryonic anterior and 
posterior cell fates (1). Without maternal D-raf, female embryos produce cuticles 
that lack head and tail structures. Phenotypic rescue of this posterior defect was 
observed after injection of wild-type D-raf mRNA (tmpublished results), but the 
percent rescue was not influenced by the presence (80%) or removal (85%) of 
leaked cytoplasm. However, since the percentage of embryonic survival was 
greater when leaked cytoplasm was removed, this procedure greatly increases the 
efficiency of the microinjection technique. Fewer embryos need to be injected to 
obtain significant experimental results. This protocol may prove useful for the 
efficient microinjection of nuclei acids into various organisms including Drosophila, 
Xenopus, Caenorhabditis, and Tetrahymena. 
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Figure 1. Drosophila microinjection set up using in-house air and vacuum lines. 
Injection was performed by turrung the air pressure line on and blocking the 
second value opening with a finger. Leaked cytoplasm was removed by 
turning the vacuum line on and covering the opening with a Pasteur-pipet 
bulb. 
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Vacuum Air 
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Table 1. Important Factors for High Viability of Microinjected Embryos 
1. Dehydrate properly 
2. Minimize and/or remove leaked cytoplasm 
3. Maintain a thin layer of Halocarbon oil over embryos 
4. Maintain high humidity 
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Table 2. Wild-Type Embryos were Injected with Nuclease-Free Distilled Water 
and Allowed to Develop for 24 h 
Leaked Embryos Embryos Embryonic 
Cytoplasm Assayed Developed Viability 
Present 173 59 34% 
Removed 136 101 74% 
Uninjected 208 181 87% 
16 
Table 3. Embryos from Homozygous D-raf^^-^^ Female Germline Clones were 
Injected with D-ra/mRNA and Allowed to Develop for 48h 
Leaked 
Cytoplasm 
Embryos 
Assayed* 
Embryos 
with 
Cuticles 
Posterior 
Rescue 
Embryonic 
Viability 
% 
Rescue 
Present 85 50 40 59% 80% 
Removed 79 78 66 99% 85% 
Urvinjected 67 65 0 97% 0% 
* Only female embryos can develop cuticles (see Reference 3). 
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CHAPTER 2: SPATIALLY DISTINCT REQUIREMENTS FOR 
CONSTITUTIVE D-RAF FUNCTION IN TORSO 
SIGNAL TRANSDUCTION 
A paper prepared for submission to Ger\es & Developmer\t 
Kwang-Hyun Baek^, John R. Fabian^, Frank Sprenger^, 
Deborah K. Morrison^, and Linda Ambrosio^'^ 
ABSTRACT 
The Raf family of serine/threonine kinases are essential components in many 
receptor tyrosine kinase (RTK) mediated signal transduction pathways. Here, we 
analyze the function of D-raf in the Torso (Tor) pathway required to specify 
cellular fates at the embryonic poles. Using mutant embryos lacking endogenous 
D-raf function, we show that D-raf s serine/threonine kinase activity is essential 
for its role in Tor signal transduction and that human Raf-1 will substitute for D-raf 
in this pathway. After Tor activation, D-raf becomes hyperphosphorylated. We 
identified two serine phosphorylation sites (S388 and 5743) and demonstrate that 
5743 or its phosphorylation is essential for D-raf function. N-terminal tnmcation of 
D-raf, serine-to-alanine substitution at 5388, or targeted membrane association 
result in constitutive. Tor-independent signal trarisduction by D-raf at the poles. 
Interestingly, membrane targeted D-raf could promote development of terminal 
structures in the embryonic center, while N-terminal deleted and serine substituted 
D-raf did not. Together, these results suggest that at the embryonic poles there is 
an activity that facilitates localization of D-raf to the membrane compartment and 
this activity is independent of Tor activation. Thus, it is likely that determination 
^Signal Transduction Training Group, Department of Zoology and Genetics, Iowa State Uruversity, 
Ames, Iowa 50011. 
^Molecular Mechanisms of Carcinogenesis Laboratory, ABL-Basic Research Program, National 
Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702. 
^Department of Biochemistry and Biophysics, University of California at San Francisco, Sein 
Francisco, California 94143. 
^Author for correspondence. 
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of cellular fates and signal transduction by D-raf at the poles rely upon at least two 
upstream events. Tor independent localization and Tor dependent activation. 
INTRODUCTION 
Polarity along the anterior-posterior axis of the Drosophila embryo is established 
by the activity of maternal gene products deposited into the egg during oogenesis. 
These activities direct specialized domains of zygotic gene expression important 
for the determination of cellular fates (Klinger 1990; Niisslein-Volhard 1991; St. 
Johnston and Niisslein-Volhard 1992). Spatial information at the termini, or 
embryonic poles, is transferred to nuclei through the activity of the Torso (Tor) 
signal transduction pathway (Lu et al. 1993). Localized activation of the Tor 
receptor tyrosine kinase (RTK) (Sprenger and Niisslein-Volhard 1992) leads to 
expression at the embryoruc poles of zygotic genes encoding the putative 
trar\scription factors, tailless (Pignoni et al. 1990) and huckebein (Weigel et al. 1990; 
Bronner and Jackie 1991), that are required for development of the embryonic head 
and tail. 
The Tor protein is evenly distributed along the embryonic membrane 
(Casanova and Struhl 1989). Spatially restricted activation of Tor relies upon 
factors encoded by the fs(l) Nasrat (Degelmann et al. 1986),/s(3) polehole (Perrimon 
et al. 1986), trunk (Schiipbach and Wieschaus 1986), and torso-like (Stevens et al. 
1990; Savant-Bhonsale and Montell, 1993; Martin et al. 1994) genes. Since these 
products act upstream of Tor, they are likely to play key roles in the production, 
accessibility and spatial distribution of the Tor ligand. Once Tor is activated along 
the syncytial membrane at the embryonic poles, its signal is transduced to 
underlying nuclei by an evolutionarily conserved set of proteins (Perrimon, 1993) 
that include D-rasl (Lu et al. 1993), and the protein kinases D-raf (Nishida et al. 
1988; Ambrosio et al. 1989a), D-MEK (Tsuda et al. 1993; Hsu and Perrimon, 1994; 
Lu et al. 1994), and MAP kinase (Biggs HI and Zipursky 1992; Biggs HI et al. 1994; 
Brunner et al. 1994). 
How the activity of D-Raf is regulated in Drosophila is not well understood at 
this time. At the amino acid level, there is 45% homology between D-raf and the 
human Raf-1 proto-oncogene with 65% identity in the serine/threonine kinase 
domain (Mark et al. 1987; Nishida et al. 1988). In mammalian cells, the kinase 
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activity of Raf-1 is regulated by multiple mechanisms. Activation of Raf-1 after 
stimulation of cells with growth factors is accomparued by association of Raf-1 
with Ras (Moodie et al. 1993; Van Aelst et al. 1993; Vojtek et al. 1993; Warne et al. 
1993; Zhang et al. 1993), the translocation of Raf-1 to the plasma membrane 
(Leevers et al. 1994; Stokoe et al. 1994), and hyperphosphorylation of Raf-1 
(Morrison et al. 1988; Morrison et al. 1989). In addition, since Raf-1 associates with 
other proteins including hsp 90, p50 (Stancato et al. 1993; Wartmarm and Davis 
1994), Fyn, Src (Williams et al. 1992; Cleghon and Morrison 1994), and 14-3-3 (Fantl 
et al. 1994; Freed et al. 1994; Fu et al. 1994; Irie et al. 1994), it is likely that Raf-1 
exists as a member of a multi-protein complex(es) (Morrison 1994). It has also been 
demonstrated that Ras, Raf-1 and MEK can form a ternary complex (Huang et al. 
1993; Moodie et al. 1993; Van Aelst et al. 1993; Jelinek et al. 1994). 
We have examined the Tor pathway to learn about the regulation of D-raf and 
its signal transduction using microinjection of D-raf mRNAs into Drosophila 
embryos. As a single large cell, the Drosophila embryo serves as an in vivo system 
in which to assay the activity and biological function of various D-raf proteir\s. By 
injecting into the ends or middle of embryos, modified forms of D-raf can be 
expressed at the poles where the Tor pathway is active or in the center where it is 
inactive. In the absence of D-raf-mediated Tor signal transduction the embryonic 
head and tail fail to develop. Rescue of this defect by the microinjection of D-raf 
mRNA is used to assess whether propagation of the Tor signal has been achieved 
by D-raf. These effects were studied without interference from endogenous D-raf 
by preparing mutant embryos lacking maternal D-raf protein. We tested wild-type 
and modified D-raf proteins with serine substitutions that alter sites of 
phosphorylation, N-terminal truncations, and membrane associated D-raf fusion 
proteins, as well as human Raf-1 to characterize their activity in the Tor signaling 
pathway. 
We find that D-raf's serine/threonine kinase activity is essential for rescue of 
the terminal defects in embryos lacking maternal D-raf. We also show that human 
Raf-1 can interact at low efficiency with Drosophila proteins to promote Tor signal 
transduction in embryos lacking maternal D-raf protein. In addition, we identified 
two sites of D-raf phosphorylation and show that one, serine S743, is essential for 
D-raf function in the Tor pathway. Tor independent, constitutive activity of D-raf 
at the embryonic poles is achieved by alanine substitution at S388, by N-terminal 
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truncation, and by targeting D-raf to the membrane. However, within the 
embryonic center only the membrane targeted forms of D-raf showed function. 
We propose that at the embryoruc poles a Tor independent activity normally 
facilitates D-raf membrane association. Once localized to the membrane, D-raf 
interacts with its substrate(s) to propagate a functional signal. 
MATERIALS AND METHODS 
Drosophila Strains 
In this study wild-type Oregon R; (Ambrosio et al. 1989b; Melnick et 
al. 1993); tnink^, trunk^ (Schiipbach and Wieschaus 1986; Lindsley and Zimm 1992); 
D-MEICLHllO (Lu et al. 1994) alleles were used. To generate germline clones of D-
rfl/11-29 and D-MEJK^HllO the 'FLP-DFS' technique was utilized (Chou and 
Perrimon 1992). 
Basic Drosophila Techniques and Microinjections 
Flies were raised on Drosophila media at 25°C using standard conditions 
(Roberts 1986; Wieschaus and Niisslein-Volhard 1986; Ashburner 1989). 
Embryos were collected on molasses agar plates and microinjected with in vitro 
synthesized mRNA using the procedure of Baek and Ambrosio (1994). Embryos at 
stages NC 9-12 were used for injection, and staging was according to Foe and 
Alberts (1983) and Campos-Ortega and Hartenstein (1985). After 48 hours at 19°C 
embryos were devitellir\ized with a sharp tungsten needle and Halocarbon oil 
(series 95, Halocarbon Products Corporation) was removed from each embryo with 
heptane. These cuticular preparations of embryos were embedded in a (1:1) 
mixture of Hoyer's: lactic acid according to van der Meer (1977) and photographed 
with a Zeiss Axioscope microscope using dark field illumination or Nomarski 
optics. 
For in vitro translation of in vitro synthesized mRNA, mRNAs were translated 
using a rabbit reticulocyte lysate kit (Amersham). Each reaction contained 10 ^il of 
reticulocyte lysate, 2 ^1 of 1 M potassium acetate, and 1 |ig of in vitro synthesized 
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mRNA. Samples were incubated for 1 hr at 37°C and analyzed by SDS-
polyacrylamide gel electrophoresis. 
The D-raf gene is located on the X-chromosome and its product is required at 
multiple stages of development. Without injection, embryos that lack maternal D-
raf protein show two phenotypic classes (Ambrosio et al. 1989b). Male embryos 
that lack maternal and paternal D-raf protein show little cuticle differentiation, and 
are not considered in this analysis. Female embryos lack maternal D-raf protein 
but inherit a paternal X-chromosome with a wild-type copy of the D-raf gene. 
These female embryos are defective only for the Tor signaling pathway. In this 
analysis, we address the question of posterior rescue for these female embryos. 
Thus, since the D-raf gene product acts in several different developmental 
pathways or\ly its maternal role in the Tor pathway has been addressed here. 
Plasmid Constructions 
D-raf and Raf-1 Constructs 
Wild-type D-raf plasmid is as described by Sprenger et al. (1993); Raf-1 as in 
Fabian et al. (1993); and Raf-1^305 as in Samuels et al. (1993). 
Site-directed Mutagenesis 
The plasmid pGEM7GLO was generated by inserting a 2.7 kb Hind ni-Eco RI 
fragment from pSP64GLO, which contained the entire coding sequence of the D-raf 
gene (residues 1-782) inserted downstream of a 56 bp 5'-untranslated leader 
sequence from the Xenopus 13-globin gene, into the corresponding sites of plasmid 
pGEM7Z(-) (Promega). Single-stranded plasmid used for mutagenesis was 
produced from the plasmid pGEM7GLO upon infecting host cells with the helper 
phage M13K07 (Vieira and Messing 1987). Oligonucleotides were synthesized to 
generate the mutations K497M (5'-CCCGTGCCCGTAATGACACTCAACGTG-3'), 
S388A (5'-CAAGACGATCGATCCAATGCCGCGCCAAATGTG-3'), and S743A (5'-
CATCGCAGTGCCGCTGAACCAAACTTG-3'). Mutants were generated by the 
method of Kunkel et al. (1987), as described by the vendor (for Biorad Mutagenesis 
Kit, Richmond, CA), and each mutation was corvfirmed by sequencing using a 
custom primer and Sequenase Version 2.0 DNA Sequencing Kit (Uruted States 
Biochemical, Cleveland, OH). 
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Deletion Mutants 
The deletion mutant D-raf^315 was generated by removing a 0.9 kb Nco I 
fragment (encoding amino acids 1-315) from the construct pGEM7GLO and re-
ligating the plasmid. Deletion mutants D-raf^^O^ D-raf^o"^ and D-rafto'4021 were 
generated as described by Dickson et al. (1992). The deletion mutant D-raf^5 was 
generated by PGR using the oligos 5'-CCGCGGCCATGGCCATGAGAGCAATAA 
AAATCTGC-3' and 5'-GGCCCGACGTCGCATGCTCCTCTAGACTCGAGG-3' as 
the 5'- and 3'- PCR primers, respectively. A 1.4 kb fragment was amplified (35 
cycles of 94°C, 1.0 min., 56'C, 1.0 min., and 72°C, 2.0 min.), extracted with 
chloroform, ethanol precipitated and subsequently digested with Nco I and Eco RI. 
The PCR fragment was gel purified, extracted, and ligated into gel purified 
pGEM7GLO which had been digested with Nco I and Eco RI. 
Expression of D-raf Proteins in Sf9 Cells 
To obtain recombinant baculoviruses expressing the mutant D-raf proteins, 
DNA fragments contairung wild-type and mutant D-raf coding sequences were 
isolated using the restriction enzymes Nco I and Eco RI and were inserted into the 
corresponding sites in the pAcC4 baculoviral transfer vector. Each of the 
recombinant transfer vectors were then co-transfected into Sf9 cells with wild-type 
AcNPV DNA, and recombinant baculoviruses isolated by plaque purification as 
described by Summers and Smith (1987). 
Phosphopeptide Mapping 
For peptide mapping, 32p labeled proteins isolated from Sf9 cells were 
separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis 
(PAGE), eluted from the gel matrix, TCA precipitated, and subjected to er\zymatic 
digestion with trypsin. Labeled polypeptides were separated on thin layer 
cellulose plates by electrophoresis at pH 1.9 for 27 min. at 1,000V, followed by 
ascending chromatography in a buffer contairiing n-butanol-pyridine-acetic acid-
water in a ratio of 75:50:15:60. 
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Yiestem Blot Analysis of Microinjected Embryos 
Translation of injected mRNA in embryos was examined by Western blot 
analysis. After injection, the embryos were incubated at room temperatxire for 1 hr 
and then the Halocarbon oil was removed with heptane. To make extracts, the 
embryos were transferred into an Eppendorf tube and homogeruzed in lysis buffer 
containing 1% Nonidet P-40, 20 mM Tris (pH 8.0), 137 mM NaCl, 10% glycerol, 2 
mM EDTA, 1 mM phenylmethylsulfonyl fluoride, aprotinin (0.15 U/ml, 20 mM 
leupeptin at a concentration of 1 embryo per 1 (Sprenger et al. 1993). Insoluble 
material was removed by centrifugation at 4°C for 10 minutes at 10,000 x g. 
D-raf protein was immunoprecipitated as described in Sprenger et al. (1993). 
Immimoprecipitates were resolved by 7.5% SDS-PAGE and transferred to 0.2 ^im 
pore nitrocellulose membrane filters (Schleicher & Schuell) electrophoretically. 
These filters were blocked with 2% bovine serum albumin (Sigma) in Tris- buffered 
saline, pH 8.0 (TBS), for 1 hour, washed in TBST (TBS containing 0.2% Tween 20), 
and probed 2 hours with primary antibody diluted in TBST. The filters then 
washed in TBST, incubated with a horseradish peroxidase-coupled secondary 
antibody for 1 hour, and washed again in TBST. They were developed by using an 
enhanced chemilununescence system (Amersham) and visualized on Kodak XAR-
5 film. 
RESULTS 
Kinase Activity of D-raf is Essential for Its Role in Terminal Development 
To determine whether the Tor signal transduction pathway could be 
reconstituted in embryos that lack maternal D-raf protein, we microinjected mRNA 
encoding either a wild-type D-raf (D-raf^) or kinase defective mutant D-raf (D-
rafK497M) protein (Sprenger et al. 1993). mRNA was injected at a concentration of 
approximately 1 |xg/|xl since this yielded levels of D-raf protein similar to that 
observed in wild-type embryos (Figure 1). After injection of D-raf^ or D-raf^^^"^ 
mRNA, embryos were allowed to develop for 24-48 hours, and analyzed for the 
presence of terminal structures. Rescue was defined by scoring for Filzkorper. 
Since less than wild-type levels of D-raf activity are required for the formation of 
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this posterior structvire (Melnick et al. 1993), this is a fairly relaxed (r\on-stringent) 
assay for Tor signal transduction. 
Figure 2 shows cuticular preparatior\s of a wild-type embryo (Figure 2A) and 
embryos that lack maternal D-raf protein from females with homozygous D-raf^^~ 
29 germlines (Figure 2B-F). In the absence of maternal D-raf, head and tail 
structures do not form (Figure 2B and 2E). After posterior injection of D-raf^ 
mRNA, rescue of pattern including Filzkorper, tuft, and anal pads was observed 
(Figure 2C). Rescue of head structures was achieved when D-raf^^ mRNA was 
injected into the head region (Figure 2D and 2F). In contrast, injection of D-
raf!^^97M mRNA encoding the kinase defective form of D-raf into the anterior or 
posterior pole of the embryo rescued neither head nor tail defects. The results of 
this analysis are summarized in Table 1. To confirm the integrity of the mRNAs 
used in this assay D-ra/mRNAs were translated in rabbit reticulocyte lysates and a 
90 kDa protein, as expected for D-raf, was synthesized (data not shown). These 
results show that the kinase activity of D-raf is essential for its fimction in the Tor 
signaling pathway. 
Mammalian Raf-1 Proteins Can Substitute for D-raf in the Tor RTK Pathway 
We tested the ability of human Raf-1 to act in the Drosophila Tor signal 
transduction pathway since there is 45% amino acid homology between D-ra/and 
Raf-1 (Mark et al. 1987; Nishida et al. 1988). In this experiment, in vitro synthesized 
Raf-1 mRNA (Fabian et al. 1993) was injected into the posterior of embryos lacking 
maternal D-raf protein. After injection, 70 embryos developed and of these 4 
embryos showed terminal Filzkorper (5.7% rescue). Thus, Raf-1 can interact at low 
efficiency with Drosophila proteins in the Tor signal transduction pathway. We also 
tested whether a highly transforming N-terminal deletion of human Raf-1, Raf-
1^305 (Samuels et al. 1993) could substitute for D-raf in embryos that lack maternal 
D-raf activity. In this case, 11% rescue of Filzkorper was achieved. These results 
indicate that there is conservation of structure amongst the components of this 
signaling cascade such that activator(s) and substrate(s) of D-raf are recognized by 
and can recognize htmian Raf-1 proteir\s. 
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Identification of D-raf Phosphorylation Sites 
Phosphorylation may be a mechanism by which the activity of D-raf is 
regulated. Maternal D-raf protein becomes phosphorylated two hours after 
fertilization in wild-type embryos (Sprenger et al. 1993). At this time the Tor RTK 
has been activated and the intracellular signal generated for zygotic expression of 
tailless. Morrison et al. (1993) have identified the major phosphorylation sites of 
the Raf-1 kinase in mammalian and recombinant baculoviral ii\fected Sf9 insect 
cells. Sequence comparison reveals that two of these phosphorylation sites (S259 
and S621) and the residues surrounding these serines (RSXSXP) are conserved in 
all Raf family members, indicating that these sites of phosphorylation may be 
required for the enzymatic activity or regulation of the Raf kinases. These serine 
residues correspond to S388 and S743 of the D-raf protein. 
To determine whether S388 and S743 are major in vivo sites of D-raf 
phosphorylation wild-type and mutant D-raf proteins with serine to alanine 
substitutions (S388A and S743A) were labeled with [32p] orthophosphate in Sf9 
cells co-ir\fected with a baculovirus that expresses an activated form of the Tor 
receptor. The labeled D-raf proteins were immunoprecipitated from cell lysates, 
separated by electrophoresis on SDS-polyacrylamide gels, extracted, digested with 
trypsin, and the phosphopeptides were analyzed by two dimensional peptide 
mapping (Figure 3). For D-raf^^ fjve labeled peptides were observed (Figure 3A 
and D). For the altered D-raf proteins D-rafS388A (Figure 3B) and D-rafS743A 
(Figure 3C) phosphopeptides A and B, respectively, were absent (Figure 3D). This 
analysis indicates that serine residues 388 and 743 serve as D-raf phosphorylation 
sites in vivo. In addition, since the phosphopeptide map of kinase defective D-
rafK497M is identical to D-raf^^^ it is unlikely that the phosphorylated peptides 
result from D-raf autophosphorylation (data not shown). 
Signaling Activity of D-raf Proteins with Serine to Alanine Substitutions 
To determine whether substitution of alarune at serine phosphorylation site 388 
or 743 alters the ability of D-raf to participate in the Tor pathway, in vitro 
synthesized mRNAs encoding these and D-rafS388A/S743A double mutant proteins 
were injected into the posterior of embryos lacking maternal D-raf protein. After 
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48 hours embryos were scored for the presence of Filzkorper and the results of 
these experiments are listed in Table 2. After injection with D-ra/S388A mRNA 
rescue of posterior pattern was observed at a level similar to that of D-raf^ 
mRNA (78% as compared to 88%). However, and the double mutant D-
j'flyS388A/S743A nvRNAs failed to promote the formation of terminal structures. 
Rescue of head structures was also observed after anterior injection of D-raj^^^ 
but not with or D-rayS388A/S743A mRNAs (data not shown). Thus, the 
presence of a serine or phosphorylation at site 743 is essential for D-raf to 
propagate the Tor signal. In contrast, lack of a serine and/or phosphorylation at 
residue 388 does not interfere with D-raf s ability to act in the Tor pathway. 
Activity of N-terminal Deleted and Membrane Associated Forms of D-raf 
Amino terminal trimcations of Raf-1 are transforming, the result of constitutive 
activation of Raf-1 kinase activity (Bonner et al. 1985; Rapp et al. 1988). Thus, 
removal of these residues relieves Raf-1 from its normal regulation (Heidecker et 
al. 1990). We tested whether D-raf proteins having N-terminal truncations would 
substitute for wild-type D-raf in the Tor pathway. For this analysis three deletions 
of D-raf were tested, D-raf^^^^ and D-raf^^5 (Figure 4). D-raf^315 lacks 
CRl which contains the putative Ras-1 binding domain and a cysteine-rich region. 
D-raf^370 lacks CRl and part of CR2, but retains the rest of CR2 and the 
serine/threonine kinase domain (CR3). D-raf^^^^ encodes only CR3. As shown in 
Table 3, when these deleted forms of D-ra/mRNAs were injected into the posterior 
of embryos that lack maternal D-raf protein, greater than 50% rescue of Filzkorper 
was achieved. These results indicate that N-terminal trimcated D-raf molecules 
can recognize and interact with their substrate(s) and transmit the Tor signal in 
Drosophila embryos. 
It has been recently shown that targeting Raf-1 to the plasma membrane results 
in a Ras independent, active form of the Raf-1 kinase (Leevers et al. 1994; Stokoe et 
al. 1994). Therefore, we also tested two deletion mutations, D-rafto"" and D-
raftor402l^ which encode the CR2 and CR3 sequences equivalent to D-raf^70 fused 
to the signal sequence, extracellular and transmembrane domains of the Tor 
protein. For D-rafto'^OZl the extracellular domain of Tor has a substitution of 
cysteine for tyrosine at position 327 that renders the protein constitutively active 
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(Sprenger and Nusslein-Volhard 1992). Since similar results were achieved for 
both forms of the chimeric Tor : D-raf protein, only the data for D-rafto''402l 
presented here. Both fusion proteins have previously been shown to induce R7 
development in the SeverUess/D-rasl signal transduction pathway in the absence 
of Sevenless RTK activity (Dickson et al. 1992). As shown in Table 3,92% rescue of 
posterior Filzkorper was observed when mRNA was injected into the 
posterior of embryos that lack maternal D-raf protein. Interestingly, a second 
effect of D-rafto'^O^l^ suppression of abdominal segmentation (Figure 5A-B) was 
observed for some of these embryos. 
Signal Transduction after Central Injection of Wild-Type and Modified D-raf mRNAs 
Sprenger and Nusslein-Volhard (1992) showed that activation of the Tor 
pathway in the middle of wild-type embryos resulted in formation of terminal 
structures in the embryonic center and suppression of the normal segmented 
pattern. We tested for a similar effect by injecting wild-type and modified forms of 
D-raf mRNAs into the middle of embryos that lack maternal D-raf protein. As 
shown in Table 4, when embryos were injected in the center with D-raf^ mRNA, 
rescue of both anterior and posterior defects was observed. Thus, D-raf was 
distributed to both ends of the embryo and participated in Tor-mediated signal 
transduction at the poles. This result is likely due to diffusion of the centrally 
injected D-raf mRNA and/or protein to the embryonic poles. Similar resvilts were 
achieved after central injection of mRNAs encoding the D-rafS388A and D.j-afA445 
proteins (Table 4; Figure 5F). However, when D-ra/or402l mRNA was injected into 
the middle of embryos lacking maternal D-raf protein, suppression of abdominal 
segmentation as well as rescue of terminal structures was observed (Table 4). 
Furthermore, as shown in Figure 5C-E, when wild-type embryos were injected in 
the middle with mRNA secondary Filzkorper developed centrally and 
abdominal segmentation was suppressed. Thus, membrane targeted D-raf 
promotes terminal development at the poles and in the middle of the Drosophila 
embryo. 
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Modified Forms ofD-raf Act Independent of Tor Activation 
To test whether D-rafS388A^ D.i.afA445^ or D-rafto''402i constitutive. Tor 
independent activity, each of these modified D-raf mRNAs were injected into 
embryos lacking trunk activity. Based upon genetic epistasis experiments trunk is 
positioned upstream of Tor in the signaling pathway and may encode the Tor 
ligand, or play a role in its accessibility. In these embryos little tyrosine 
phosphorylation of Tor is observed while high levels are detected for the wild-type 
activated Tor receptor (Sprenger et al. 1993). Table 5 lists the results of these 
experiments. After posterior injection into trunk embryos, rescue of Filzkorper was 
achieved for all mutant D-raf mRNAs tested. Thus, these modified forms of D-raf 
show constitutive activity at the poles, and in the absence of Tor activation 
transmit the terminal signal. 
In addition, these modified D-ra/mRNAs were tested in embryos that lack D-
MEK activity. D-MEK has been shown to act downstream of D-raf in the Tor 
signaling pathway (Tsuda et al. 1993; Lu et al. 1994). Posterior structures were not 
produced after expression of the modified D-raf proteins in embryos lacking D-
MEK, indicating that constitutive activation of D-raf did not result in utilization of 
aberrant signaling pathways (data not shown). 
DISCUSSION 
The Tor pathway is activated when the Drosophila embryo is a syncytium. In 
this single large cell the subcellular localization of maternal gene products has been 
detected using genetic approaches and also by direct visualization. At the anterior 
and posterior poles high concentrations of maternal bicoid and nanos mRNA 
accumulate, respectively (Niisslein-Volhard 1991). Both protein products form 
gradients that direct determination of cell type and establish the anterioposterior 
embryonic axis. As a large single cell, the Drosophila embryo is easily amenable to 
phenotypic rescue by microinjection. Since mutations in various gene products of 
the Tor pathway have been characterized they serve as good backgrounds in 
which to add wild-type or to assay the activity of altered signaling components. 
Thus, we have used the Tor signal transduction pathway to test the fimction of 
modified D-raf proteins in an in vivo developmental context. D-raf mutations were 
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generated to address the mechanism(s) that regulates its activity or facilitates 
access to its substrate(s). This system offers a rapid approach for structure/ 
function analysis of the Raf family of serine/threonine kinases as well as other 
molecules that participate in the evolutionarily conserved signaling module 
utilized by receptor tyrosine kinases (Perrimon 1993). 
Serine/Threonine Kinase Activity ofD-rafis Essential for Tor Signal Transduction 
It has been previously shown that D-raf autophosphorylates and acts as a 
serine/threonine kinase in vitro when incubated with Mn2+ and [32p]ATP 
(Sprenger et al. 1993). In addition, Melnick et al. (1993) showed that two mutations 
of D-raf that gave a null phenotype in the Tor pathway were associated with single 
amino acid substitutions within the conserved region of D-raf's kinase domain. 
These two findings strongly indicate that D-raf functions as a serine/threonine 
kinase in Drosophila, and that this activity is required for Tor signal transduction. 
However, a kinase dependent as well as an independent requirement, related to 
subcellular localization and/or participation in a multiprotein complex, has been 
shown for the Drosophila Abelson tyrosine kinase (Henkemeyer et al. 1988; 
Henkemeyer et al. 1990). Thus, here we show directly that a point mutation that 
inactivates the D-raf serine/threonine kinase in vitro (Sprenger et al. 1993) also 
abrogates the ability of the protein to act in the Tor pathway. Thus, D-raf's kinase 
activity is essential for it's function in Tor signal transduction. 
Conservation of Structure and Function of Signal Transduction Molecules 
We tested whether human Raf-1 could participate and showed that it can 
interact at low efficiency with Drosophila proteins in the Tor signal transduction 
pathway. In addition, the highly transforming N-terminal deletion form of Raf-1, 
Raf-1^305 (Samuels et al. 1993), could substitute for D-raf in embryos that lack 
maternal D-raf activity. Overall, these results show that there is structural 
conservation between the components of this signaling cascade and that 
activator(s) and substrate(s) of D-raf are recognized by and can recognize the 
human Raf-1 proteins. Thus, it is likely that we can use the genetics of Drosophila 
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to gain a better understanding of the mechanisms utilized for signal transduction 
as it pertains to the control of growth and development in higher organisms. 
Phosphorylation as a Mechanism for D-raf Regulation 
Protein kinases and phosphatases play a critical role as mediators in signal 
transduction pathways. Reversible protein phosphorylation is a good mechanism 
by which to regulate developmental choices. Two phosphorylation sites have been 
mapped for the D-raf kinase, serine residue S388 and S743. These sites are 
phosphorylated when D-raf protein is isolated from Sf9 insect cells co-infected 
with activated Tor RTK and D-raf. These two residues and surroimding residues 
(RSXSXP) are conserved among members of the Raf family of protein kinases and 
correspond to serine 259 and 621 of the Raf-1 protein (Morrison et al. 1993). Since 
phosphorylation occurs at these sites for the kinase defective D-rafK497M protein, 
these events are not due to autophosphorylation. Rather phosphorylation at these 
serine residues appears to be dependent upon another kinase(s) and thus, these 
sites are potentially important for the regulation of D-raf activity. 
Substitution of an alanine at residue S743 rendered the D-raf protein inactive, 
while substitution at site S388 was permissive and resulted in constitutive activity 
independent of Tor activation. This result is consistent with that observed for Raf-
1 when the homologous amino acid substitutions were tested. In in vitro kinase 
assays Raf-lS62lA had no activity while Raf-lS259A haj ^ fold increase in 
kinase activity when compared to wild-type Raf-1 (Morrison et al. 1993). Thus, it 
appears that there is functional conservation of these two phosphorylation sites 
indicating that the mechanisms for modulating Raf activity are evolutionarily 
conserved. Phosphorylation could serve to alter the conformation of the Raf 
protein, it's enzymatic activity, it's interactions with other molecules, or a 
combination of these modifications. 
Regulation ofN-terminal Deletion Mutants of D-raf 
The Tor receptor upon binding ligand likely undergoes dimerization, 
autophosphorylation (Sprenger et al. 1993), and recruitment of Drk and Sos to the 
membrane (Buday and Downward 1993; Olivier et al. 1993; Simon et al. 1993). In 
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turn, it is likely that Sos promotes the exchange of GDP for GTP on D-rasl which 
stimulates the interaction between D-rasl and D-raf, facilitating the activation of 
D-raf which then activates D-MEK. The process is dynamic and likely requires 
movement and spatial rearrangement of multi-protein complexes. In embryos that 
lack maternal D-raf protein, this series of events is halted by the absence of the D-
raf protein. It is in this context that truncated versions of D-raf can act to transmit 
a signal. We tested three different N-terminal deletions each encoding the D-raf 
kinase domain that effectively participated in signal transduction. This result 
indicates that at least a fraction of the truncated D-raf molecules recogruze, have 
access to, and can interact with the substrate(s) of the full length wild-type D-raf 
protein. 
D-raf Membrane Association and Terminal Development in the Embryonic Center 
Raf-1 targeted to the plasma membrane by N-terminal fusion with a Ras 
membrane localization signal shows constitutive activation in assays of MEK and 
MAP kinase activities (Leevers et al. 1994; Stokoe et al. 1994). Its constitutive 
activation was confirmed by demonstrating that membrane localized Raf-1 induces 
neurite outgrowth in PC12 cells and morphological trarisformation of NIH3T3 cells 
(Leevers et al. 1994). Thus, it appears that membrane association of Raf-1 is a key 
toward achieving activation of downstream signaling components in the 
Raf/MEK/MAP kinase cascade. When an N-terminal truncated D-raf is targeted 
to the embryonic membrane by fusion with the signal sequence, extracellular and 
transmembrane domains of Tor, this chimeric D-raf protein directs the formation 
of Filzkorper at the posterior pole. In addition, this mutant D-raf protein 
suppresses the formation of abdominal pattern and directs the formation of 
terminal structures in the center of the embryo. Thus, by anchoring D-raf to the 
membrane it acts constitutively in the embryonic center to activate downstream 
components of the Tor signaling pathway. 
Since membrane localization appears to be a key in achieving biological 
function for the Raf family of serine/threonine kinases, we propose that D-raf must 
also be recruited to the membrane for functional activation of its downstream 
target(s). Thus, when N-terminal deleted or serine substituted forms of D-raf were 
tested for constitutive activity by mRNA injection into the embryonic center. 
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rescue of terminal pattern was observed at the poles of embryos lacking D-raf 
activity. However, unlike the membrane targeted D-raf these mutant forms of D-
raf did not show biological activity in the central domain. A similar restilt was also 
shown for central injection of wild-type D-raf n\RNA. Since an even distribution of 
D-raf mRNA was foimd in the early Drosophila embryo (Ambrosio et al. 1989a), it is 
likely that D-raf mRNAs injected into the central domain diffuse outward from the 
point of injection and are distributed to both central and polar regions. 
When mutant Tor receptor is active in the central abdominal domain normal 
segmentation is suppressed and posterior structures develop in the middle of the 
embryo (Klinger et al., 1988; Sprenger et al. 1989). Similarly, Lu et al. (1993) 
showed that expression of activated Ras-1 could initiate terminal development 
within the central domain of wild-type embryos. Since functional D-raf activity is 
required for the expression of the constitutive Tor phenotype (Ambrosio et al. 
1989a) this indicates that wild-type D-raf can associate with the membrane 
centrally to propagate the signal. In mammalian cells RTK activation directs the 
formation of Ras/Raf-1 complexes at the membrane and this facilitates efficient 
activation of Raf-1 (Leevers et al. 1994; Stokoe et al. 1994). Indeed, it has been 
demonstrated that Ras, Raf-1 and MEK can form a ternary complex (Huang et al. 
1993; Moodie et al. 1993; Van Aelst et al. 1993; Jelinek et al. 1994). Thus, it is likely 
that in the central domain of a Drosophila embryo activation of Tor and/or D-rasl 
results in the recruitment of D-raf to the membrane by its interaction with D-rasl. 
Modified Forms of D-raf Act Constitutively and Independent of Tor Activation at the Poles 
Activation of Tor RTK is regulated by a diffusible ligand produced at the 
extracellular terminal regions of the Drosophila embryo (Sprenger and Niisslein-
Volhard 1992). Since the ligand is limited in amount, and normally boxmd by Tor 
at the poles, this results in a spatially restricted pattern of activated Tor receptor. 
Based upon genetic epistasis experiments trunk is positioned upstream of Tor in 
the signaling pathway and may encode the Tor ligand, or play a role in its 
accessibility. In trunk mutant embryos little tyrosine phosphorylation of Tor is 
observed (Sprenger et al. 1993) correlating with the absence of head and tail 
structures later in development (Schiipbach and Wieschaus 1986). Thus, along the 
entire embryonic membrane for trunk embryos, and for the central membrane of 
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wild-type embryos, the Tor receptor is preserit, but is not activated. In these 
embryos, nuclei are directed to develop a non-terminal fate. 
We find that when N-terminal deleted, serine substituted and membrane 
targeted mutant D-raf proteins are expressed at the posterior of trunk mutant 
embryos they act constitutively and direct the specification of terminal cell fates in 
the absence of Tor activation. Since these constitutive forms of D-raf do not rescue 
the Tor signaling defect in embryos that lack D-MEK activity, it is unlikely that 
propagation of these signals involve phosphorylation of aberrant substrates. 
A Model for Localization of D-raf to the Membrane 
In summary these findings indicate that association of D-raf with the 
membrane is essential for its biological fimction in Tor signal transduction. Here, 
we propose that in the Drosophila embryo there is an intracellular activity at the 
poles that facilitates association of the D-raf serine/threonine kinase with the 
membrane (Fig. 6A). This factor acts in the absence of Tor activation to recruit D-
raf to the membrane (Fig. 6B). This factor may escort D-raf and/or facilitate its 
membrane association by providing a docking platform. It is possible that other 
components of this pathway also show membrane association at the termini. 
When Tor and/or D-rasl are active within the central domain D-raf is recruited to 
the membrane by its interaction with activated D-rasl (Fig. 6C). In this model 
activated D-raf phosphorylates and activates D-MEK which is a downstream target 
to propagate the Tor signal. Thus, in wild-type embryos two independent 
pathways are utilized at the poles for propagation of the Tor signal by D-raf. There 
is a Tor independent pathway that facilitates D-raf's association with the 
membrane and Tor dependent D-raf activation, e.g. phosphorylation by a Tor 
dependent kinase. This developmental strategy may have evolved to ensure 
efficient interaction between activated D-rasl and D-raf by increasing the 
availability of D-raf molecules at the membrane. Thus, specification of terminal 
cell fates appears to rely on a system redundant for D-raf membrane localization. 
However, this mechanism may pernait rapid transmission of extracellular signals 
during development in Drosophila. 
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Table 1. Microinjection of D-rafmRNA into embryos that lack maternal D-raf 
protein. 
Region D-raf Number of Nvimber of Rescue of Percent 
(egg length) mRNA injected embryos Filzkorper or rescue 
___onm=Enn==sBa===sa==E====a=aasJ^^^L==i^^ i^ ^^ lilss^ i^il:^ ^^ iss===i==== 
Posterior wild-type 120 57 50 88 % 
(90% -100%) K497M 199 75 0 0 % 
Anterior wild-type 137 75 65 87 % 
(0% -10%) K497M 178 64 0 0 % 
* Male embryos from D-ra/mutant germlines do not develop cuticles (Materials and Methods). 
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Table 2. Microinjection of serine to alaiune substituted forms of D-ra/mRNA 
into the posterior region of embryos lacking maternal D-raf protein. 
Number of Number of Rescue of Percent 
D-rfl/mRNA injected embryos with Filzkorper rescue 
embryos cuticles* (%) 
S388A 143 80 62 78% 
S743A 196 92 0 0 % 
S388A/S743A 151 83 0 0 % 
* Male embryos from D-ra/mutant germlines do not develop cuticles (Materials and Methods). 
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Table 3. Microinjection of mRNAs encoding N-terminal deleted and a membrane 
targeted D-raf into the posterior region of embryos lacking maternal D-raf 
protein. 
D-raf Number of Number of Rescue of Percent Suppression 
mRNA injected embryos with Filzkorper rescue of abdominal 
embryos cuticles* (%) segmentation 
D-rafA315 153 86 49 57% No 
D-rafA370 120 68 37 54% No 
D-rafA445 160 95 90 95% No 
D-rafto»"4021 85 51 47 92% Yes 
* Male embryos from D-raf mutant germlines do not develop cuticles (Materials and Metiiods). 
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Table 4. Microinjection of mRNAs encoding wild type, a serine substituted, an N-
terminal deleted, and a membrane targeted D-raf protein into the middle region 
of embryos lacking maternal D-raf protein. 
D-raf 
mRNA 
Number of Number of Rescue of 
injected embryos Filzkorper 
embryos with cuticles* or medial 
tooth 
D-rafWT 
D-raf^®®^ 
D-rafA445 
D-raftor4021 
136 
88 
130 
78 
68 
39 
53 
40 
49 
33 
42 
38 
Percent Suppression 
rescue of abdominal 
segmentation 
72% 
85% 
79% 
95% 
No 
No 
No 
Yes 
* Male embryos from D-ra/mutant germlines do not develop cuticles (Materials and Methods). 
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Table 5. Microinjection of mRNAs encoding a serine substituted, an N-terminal 
deleted, and a membrane targeted D-raf into the posterior region of trunk 
mutant embryos. 
D-raf Number of Number of Rescue of Percent 
mRNA injected embryos with Filzkorper rescue 
embryos cuticles (%) 
D-rafS388A 271 115 32 28 % 
D-rafA445 336 135 36 27 % 
D-raftor^OZl 346 207 48 23 % 
Figure 1. Accumulation of D-raf protein resulting from in vivo translation of 
wild-type D-ra/mRNA after microinjection into embryos that lack maternal D-
raf protein were microinjected and after one hour of incubation at 22°C, 
processed and D-raf protein immunoprecipitated from embryonic extracts then 
resolved by SDS-PAGE (7.5 % polyacrylamide gel) and examined by 
immunoblotting using a D-raf specific antibody. (A) Accumulation of 90 kDa 
D-raf protein in wild-type embryos. (B) Lack of D-raf protein in embryos 
generated from homozygous D-raf^^-^^ germline females after injection of 
distilled water. (C-F) Accumulation of D-raf protein in embryos produced by 
D-ra/^^"29 germline females after injection of increased concentrations of wild-
type D-rfl/mRNA. Embryos injected with 0.75 (ig/^il - 1.0 Hg/^il D-rafmRNA 
accumulate an essentially wild-type level of D-raf protein. Rescue of posterior 
pattern was observed for embryos injected with 0.50 ^g/|il - 1.5 |ig/^il D-raf 
mRNA. 
Wild Type (Orepon - R) 
Q O ug/ul 
0.5 ug/ul 
0.75 ug/u! 
1 .0  ug /u l  
1.5 ug/ul 
Figure 2. Induction of terminal structures in D-ra/embryos that lack maternal 
D-raf protein after injection of wild-type D-raf mRNA. Cuticular preparations 
of embryos are shown after the completion of embryonic development. (A) A 
wild-type embryo from a wild-type mother with Filzkorper (arrow) and 
involuted head skeleton. (B) An embryo that lacks maternal D-raf protein, both 
head and tail structures are deleted. (C) An embryo from a homozygous D-
^flyll-29 germline female after injection of wild-type D-raf mRNA showing 
rescue of posterior terminal structures including Filzkorper (arrow). (D and F) 
Embryos from a homozygous D-raf germline female after injection of D-raf 
mRNA showing rescue of head skeleton. (E) Truncated head skeleton of an 
embryo lacking maternal D-raf protein. Abbreviations: (db) dorsal bridge; 
(vpp) ventral posterior process. 
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Figure 3. Two dimensional phosphopeptide maps of wild-type and D-raf proteins with serine to alarune 
substitutions. (A) D-raf^^ (B) D-rafS388A (cj D.j.afS743A (£>) Schematic representation of five D-raf 
phosphopeptides. 
A. Wild-type/D-Raf B. S388A/D-Raf C. S743A/D-Raf D. D-Raf 
Phosphopeptides 
Figure 4. Linear representations of the primary amino acid structure for wild-type and modified D-raf proteins. 
CRl contains the putative Ras-1 binding domain and a cysteine zinc finger-like motif, the CR2 is rich in serines 
and threonines, and CR3 encodes the serine/threonine kinase domain. Listed are the three amino acid 
substitutions used in this study and their positions within D-raf. In addition three deletion mutations of D-raf, 
and a deleted, fusion D-raf protein targeted to the membrane by the signal sequence, extracellular and 
transmembrane domains of the Tor protein are depicted. Abbreviations: (EC) extracellular domain; (TM) 
transmembrane domain. 
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Figure 5. Ii\ductior\ of terminal structures in D-raf mutant and wild-type 
embryos after injection of D-rafto'^^OZl or D-raf^3l5 mRNA. Cuticular 
preparations of embryos are shown after the completion of embryonic 
development. (A and B) Embryos from a homozygous D-raf^^-^^ germline 
female after injection with D-raf^o'^O^l mRNA showing rescue of posterior 
terminal structures including Filzkorper with some suppression of abdominal 
segmentation (arrow). (C, D and E) Embryos from a wild-type mother after 
injection into their middle regions with D-raf'o''4021 mRNA showing 
suppression of abdominal segmentation and formation of extra Filzkorper 
material and Filzkorper (arrows). (F) Embryo from a homozygous D-ra/^^-29 
germline female after central injection of D-raf^^l^ showing rescue of posterior 
terminal structures including Filzkorper (arrow) and wild-type pattern of 
abdominal segmentation. For these experiments, approximately 0.25-0.50 
^ig/^l of D-rfl/to"^402l mRNA was used for injection since higher concentrations 
resulted in abnormal embryonic development, and little cuticle was formed. 
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Figure 6. A model for induction of terminal development in Drosophila: At the 
poles of a wild-type Drosophila embryo there is an intracellular activity that 
facilitates association of the D-raf serine/threonine kinase with the membrane. 
Activation of Tor by ligand binding results in D-rasl activation and promotes 
interaction between D-raf and D-rasl. D-raf is then activated in a Tor 
dependent manner and phosphorylates D-MEK its downstream target to 
propagate the Tor signal. Other components of this pathway may also show 
membrane association at the termini. A) A wild-type embryo with D-raf bound 
to its localizing factor at the posterior pole. This complex is absent along the 
membrane in the central domain and both Tor and D-rasl remain inactive. (B) 
At the embryonic poles in trunk mutant embryos Tor is not activated but D-raf 
is recruited to the membrane by its localizing factor. This factor may escort D-
raf to the membrane compartment and/or facilitate its membrane association 
by providing a docking platform. (C) When Tor and/or D-rasl are active 
within the central domain D-raf is recruited to the membrane by its interaction 
with activated D-rasl. A torso mutant embryo that has constitutive (gain-of-
function or g-o-f) is depicted here. 
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CHAPTER 3: TEMPORAL AND DOMINANT NEGATIVE EFFECTS 
OF D-RAF IN TORSO SIGNAL TRANSDUCTION 
A paper prepared for submission to Development 
Kwang-Hyun Baek, Kori Radke, and Linda Ambrosio* 
ABSTRACT 
The maternal D-raf serine/threorune kinase acts downstream of Torso for 
specification of cell fates at the embryonic termini. We find that the optimal period 
at which activation and Torso signal transduction by D-raf occurs is between 
nuclear cycle 4 and 12. Also, we show that zygotic expression of the D-raf gene 
occurs between 2 and 3 hours after fertilization, or at nuclear cycle 13, 14 and 
blastoderm stages of development. Thus, little or no paternal D-raf protein acts in 
Tor signaling. We also show that maternal D-raf^OOBS and D-rafC2Z2 proteins 
exhibit dominant negative effects and inhibit rescue of mutant embryos injected 
with D-raf^^ mRNA. We tested three constitutive. Torso independent mutant 
forms of D-raf for suppression of these effects. Expression of membrane targeted 
D-raf directed formation of terminal structures in embryos contairung either D-
raf^OOBS or D-rafC2Z2 proteins, and D-raf lacking serine at phosphorylation site 
5388 suppressed the effect of maternal D-raf^OOBS proteins, while suppression was 
not observed after expression of N-terminal truncated D-raf. Based upon these 
findings we propose that signaling by D-raf is involved in interaction with its 
substrate at a membrane-associated site. This site of action is blocked by the D-
rafC2Z2 protein, but not by D-raf^00B8. Membrane targeted D-raf has an access to 
its substrate independent of this site, while D-rafS388A requires this site to interact 
with its substrate. Since N-terminal deleted D-raf does not suppress the effect of 
D-raf400B8^ this indicates that N-terminal regulatory region permits D-raf access to 
its substrate in this background. We also characterized six other D-ra/alleles for 
^Author for correspondence. 
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dominant effects, and showed the correlation of reduced levels of rescue after 
injection of wild-type D-raf mRNA with nonfunctional maternal D-raf proteins. 
INTRODUCTION 
In Drosophila, the Torso (Tor) signal transduction pathway represents a simple 
switch and ultimately provides nuclei that lie at the embryonic termini with 
information necessary to determine their fates (Casanova and Struhl, 1989; 
Sprenger et al., 1989). The D-raf serine/threonine kinase, acting downstream of 
the Tor receptor tyrosine kinase (RTK), is required at many developmental stages 
to propagate signals that regulate cellular proliferation, determination and 
differentiation. For pattern formation in the early embryo, maternal D-raf is 
responsible for specifying cell identities at the embryonic poles. The signal 
transduction cascade ultimately leads to the activation of zygotic tailless (Pignoni et 
al., 1990) and huckebein (Weigel et al., 1990; Brormer and Jackie, 1991) gene 
expression in nuclei at the termini. These transcription factors regulate expression 
of the structural genes needed for head and tail development. Activation of D-raf 
is also triggered by the sevenless (Dickson et al., 1992) and Drosophila EGF 
receptors (Brand and Perrimon, 1994), in larval and ovarian follicle cells 
respectively, for determination of cell identity. Thus, temporal as well as spatial 
control of D-raf activation is a mechanism by which cell choice is regulated during 
development. 
Transmission of these cell determination signals from the cell membrane to the 
nucleus depends upon the function of an evolutionarily conserved signaling 
module consisting of Ras/Raf/MEK/MAPK homologs utilized in both 
invertebrate and vertebrate development (Egan and Weinberg, 1993; Perrimon, 
1993; Dickson and Hafen, 1994). Following ligand binding, the receptor tyrosine 
kinase (RTK) dimerizes leading to transphosphorylation on tyrosine residues (van 
der Geer et al., 1994). These phosphotyrosines then serve as attachment sites for 
the adapter protein, Grb2 (Drk in Drosophila), that couples with the guanine 
nucleotide-releasing factor. Son of sevenless (Sos), forming the membrane-
localized activating complex for Ras. Thus, the activation of the receptor tyrosine 
kinase (RTK) leads to the recruitment of the Grb2, Sos, the Ras GTPase, Raf, and 
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two other kinases MEK, a putative tyrosine/threonine kinase, and MAP kinase (Lu 
et al., 1993) to the membrane. 
It has been demonstrated that the effects of nerve growth factor (NGF) and 
epidermal growth factor (EGF) on PC12 cell differentiation are different (Traverse 
et al., 1994). This is based upon differences in the extent and duration of MAP 
kinase activation in response to these two growth factors. NGF can induce 
prolonged activation and nuclear translocation of MAP kinases in PC12 
phaeochromocytoma cells. In contrast, stimulation with EGF leads to a transient 
activation of MAP kinases without distinct nuclear translocation (Gotoh et al., 
1990; Traverse et al., 1992). This suggests that differential activation of signal 
transduction pathways is the basis of the differential cellular response to different 
factors at different stages of development. We address in this report when the Tor 
signal trarvsduction pathway is required for the development of embryo. 
It is likely that to achieve maximal activation of Raf-1 a complicated series of 
independent and interdependent events occur. Raf-1 has an N-terminal regulatory 
region and a C-terminal catalytic region (Bonner et al., 1986; Beck et al., 1987; Rapp 
et al., 1988). The N-terminal contains a cysteine rich domain (CRl) and a 
serine/threonine rich domain (CR2). Recent research has demonstrated that Rasl 
binds the CRl domain of Raf-1 (Moodie et al., 1993; Van Aelst et al., 1993; Vojtek et 
al., 1993; Warne et al., 1993; Zhang et al., 1993) and recruits it to the membrane 
(Leevers et al., 1994; Stokoe et al., 1994). This association of Raf-1 with Rasl may 
not affect the activity of Raf-1, but is used by the cell for localization of Raf-1 to the 
membrane. Williams et al. (1992) have foimd that cells co-transfected with Raf-1 
and either v-Src or v-Ras showed limited Raf-1 autokinase activity. However, a 
synergistic effect was observed resulting in full activation of Raf-1 when cells were 
transfected with Raf-1, v-Ras, and v-Src. This indicates that the signal transduction 
pathway may not be linear, and that parallel pathways for Raf-l's activation likely 
exist. 
Recently, Baek et al. (Submitted) have shown that the localization of D-raf to 
the membrane at the embryonic poles occurs independent of Tor activation. Three 
modificatior\s of D-raf were used in this study: N-terminal truncation, alanine 
substitution at serine site S388, and addition of sequences that target D-raf to the 
membrane. Expression of these mutant D-raf proteins leads to constitutive Tor 
independent signal transduction at the poles. However, only membrane targeted 
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D-raf showed phenotypic activity in the embryoruc center. Based upon these 
results, it was proposed that a Tor independent pathway facilitates D-raf 
association with the membrane at the poles. In the current model, activation of Tor 
results in the formation of D-ras/D-raf complexes. After the activation of the 
pathway, D-ras/D-raf complexes are formed to promote the efficient activation of 
D-raf in a Tor dependent manner. D-raf then acts to phosphorylate and activate D-
MEK, which is a downstream target to propagate the Tor signal. Thus, for Tor 
signal transduction by D-raf, at least two inputs are required, association with the 
membrane to localize D-raf to its activator(s) and/or substrate(s) and Tor 
dependent D-raf activation. 
Biochemical studies have shown that hsp 90 forms heteromeric complexes with 
a 50 kDa protein (p50) and other proteins (Whitelaw et al., 1991). Also, 300-500 
kDa Raf complex was detected during gel filtration chromatography. It is likely 
that this complex contains two molecules of hsp 90, one (or more) molecule(s) of 
p50, and Raf protein kinase (Wartmann and Davis, 1994). It has been reported that 
in Saccharomyces cerevisiae the activation of a protein kinase cascade, transmitting 
the signal through Stell (a MEKK), Ste7 (a MEK), and Fus3/Kssl (a MAPK), is 
required for mating. Genetic and biochemical studies have shown that STE5 binds 
to STEll, STE7, and either FIJS3 or KSSl, simultaneously (Choi et al., 1994). Since 
it has also been reported that Ras and 14-3-3 protein bind Raf-1 (Moodie et al., 
1993; Van Aelst et al., 1993; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., 1993; 
Fanti et al., 1994; Freed et al., 1994;; Fu et al., 1994; Irie et al., 1994) and Raf-1 binds 
MEK (Huang et al., 1993; Macdonald et al., 1993; Jelinek et al., 1994), it is possible 
that there is a multiprotein complex at the membrane to transduce the signal. 
The Raf family of serine/threonine kinases have also been shown to participate 
in vertebrate development in Xenopus for progesterone-stimulated meiotic 
maturation of oocytes (Fabian et al., 1993) and FGF-induced formation of posterior 
embryonic mesoderm (MacNicol et al., 1993). For both of these signaling 
pathways, the requirement for Raf-1 function was identified by expression of a 
kinase defective Raf-1 protein that blocked induction of either oocyte maturation 
or formation of embryonic mesoderm. Although the mechanism by which the 
mutant Raf-1 exhibited a dominant negative effect and inhibited endogenous Raf-1 
function was not determined, it was suggested that this may be due to 
sequestration of a positive regulator required for Raf-1 activity. In murine cells it 
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was shown that the activation of wild-type endogenous Raf-1 was blocked by 
expression of the amino terminal half of Raf-1 due to its interaction with a positive 
activator (Kolch et al., 1991; Bruder et al., 1992). We address here whether 
nonfunctional D-raf proteins can affect the signal transduction of D-raf proteins 
translated in vivo by microinjection. 
In this study we characterize the temporal requirements for D-raf activity and 
show that between nuclear cycle 4 (NC 4) and 12 activation and signal 
transduction by D-raf in the Tor pathway is optimal. In addition, we show that 
zygotic expression of the D-raf gene begins at 2-3 hours after fertilization (NC 13 -
blastoderm stages). Thus, this finding is in agreement with phenotypic analyses 
that indicate the paternal D-raf gene does not contribute to signaling in the Tor 
pathway (Perrimon et al., 1985; Ambrosio et al., 1989). Here we also test whether 
Tor signal transduction is influenced by pools of endogenous mutant D-raf protein. 
We find that in the presence of maternal D-raf^OOBS and D-rafC2Z2 proteins rescue 
by injection of D-raf^ mRNA is inhibited. Three constitutively active forms of D-
raf were tested for suppression of these effects. By targeting D-raf to the 
membrane, both dominant negative effects were suppressed and rescue at the 
posterior pole was achieved. However, D-rafS388A containing an alarune at serine 
phosphorylation site S388, suppressed the effect of maternal D-raf^00B8 but not D-
rafC2Z2 proteins. N-terminal truncated D-raf did not show rescue. Together, these 
results are corisistent with the idea that in the Tor signaling pathway, maternal D-
rafC2Z2 occupies a site utilized for D-raf s interaction with its substrate(s). This 
defect is suppressed by targeting D-raf directly to the membrane. In the case of 
endogenous D-raf400B8 this site of action becomes available to full length D-
rafS388A^ but not N-terminal truncated D-raf. We also characterized six other D-raf 
alleles for dominant effects, and showed that there is a correlation of reduced 
levels of rescue with nonfunctional maternal D-raf^^^OS and D-raf'®^ proteins. 
MATERIALS AND METHODS 
Drosophila Strains 
In this study, wild-type Oregon R and D-raf mutant alleles utilized are as 
described in previous reports (Nishida et al., 1988; Lindsley and Zimm 1992; 
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Melnick et al., 1993). To generate germline clones of D-ra/alleles the 'FLP-DFS' 
technique was utilized (Chou and Perrimon, 1992). 
Basic Drosophila Techniques and Microinjections 
Flies were raised on Drosophila media at 25°C using standard conditions 
(Roberts, 1986; Wieschaus and Nusslein-Volhard, 1986; Ashburner, 1989). 
Embryos were collected on molasses agar plates and microinjected with in vitro 
synthesized mRNA using the procedure of Baek and Ambrosio (1994). For 
microinjection, staging was determined according to Foe and Alberts (1983) and 
Campos-Ortega and Hartenstein (1985). After 48 hours at 19°C embryos were 
devitellinized with a sharp tungsten needle and Halocarbon oil (series 95, 
Halocarbon Products Corporation) was removed from each embryo with heptane. 
These cuticular preparations of embryos were embedded in a (1:1) mixture of 
Hoyer's: lactic acid according to van der Meer (1977) and photographed with a 
Zeiss Axioscope microscope using dark field illumination. 
For in vitro trarrslation of in vitro synthesized mRNA, mRNAs were translated 
using a rabbit reticvdocyte lysate kit (Amersham). Each reaction contained 10 nl of 
reticulocyte lysate, 2 jil of 1 M potassium acetate, and 1 \ig of in vitro synthesized 
mRNA. Samples were incubated for 1 hr at 37°C and analyzed by SDS-
polyacrylamide gel electrophoresis. 
The D-raf gene is located on the X-chromosome and this gene product is 
required at multiple stages of development. Without injection, embryos that lack 
maternal D-raf protein show two different phenotypic classes (Ambrosio et al., 
1989). Male embryos that lack maternal and paternal D-raf protein show little 
cuticle differentiation, and are not considered in this analysis. Female embryos 
lack maternal D-raf protein but inherit a paternal X-chromosome with a wild-type 
copy of the D-raf gene. These female embryos are defective for the Tor signaling 
pathway. In this analysis, we address the question of posterior rescue for these 
female embryos. Thus, since the D-raf gene product acts in several different 
developmental pathways only its maternal role in the Tor pathway has been 
addressed here. 
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Plasmid Constructions 
Wild-type and modified D-raf plasmids are as described in Baek et al. 
(Submitted). 
Western Blot Analysis of Embryos 
Embryos were collected 0-2 and 2-4 hours after egg laying, dechorionated, 
transferred to an Eppendorf tube and homogenized in lysis buffer containing 1% 
Nonidet P-40, 20 mM Tris (pH 8.0), 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1 
mM phenylmethylsulfonyl fluoride, aprotinin (0.15 U/ml, 20 mM leupeptin at a 
concentration of 1 embryo per 1 nl (Sprenger et al., 1993). Insoluble material was 
removed by centrifugation at 4°C for 10 minutes at 10,000 x g. 
D-raf protein was immunoprecipitated as described in Sprenger et al., (1993). 
Immunoprecipitates were resolved by 7.5% sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) and transferred to 0.2 |im pore 
nitrocellulose membrane filters (Schleicher & Schuell) electrophoretically. These 
filters were blocked with 2% bovine serirni albumin (Sigma) in Tris-buffered saline, 
pH 8.0 (TBS), for 1 hour, washed in TEST (TBS containing 0.2% Tween 20), and 
probed 2 hours with primary antibody diluted in TBST. The filters then washed in 
TBST, incubated with a horseradish peroxidase-coupled secondary antibody for 1 
hour, and washed again in TBST. They were developed by using an enhanced 
chemilimiinescence system (Amersham) and visualized on Kodak XAR-5 film. 
RESULTS 
Age Dependent D-raf Mediated Rescue 
Tor protein first appears at nuclear cycle 4 (NC 4) on the surface of the 
embryonic membrane (Casanova and Struhl, 1989) and zygotic tailless {til) gene 
expression begins about 60 minutes later at NC 11 (Pignoru et al., 1990; 1992). It is 
during this interval that activation of Tor and D-raf is required to transduce the 
terminal signal from the membrane into nuclei at the embryonic poles. To 
determine when activation of D-raf is required to transmit the Tor signal, D-raf^ 
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mRNA at 1 ng/^l was injected into embryos from mothers with 
homozygous mutant germlines. These embryos lack maternal D-raf protein 
(Sprenger et al., 1993). When embryos were injected at cleavage stages (NC 4-8) or 
at the time of pole cell formation (NC 9-12), 83% and 75% of the embryos 
developed Filzkorper, respectively (Table 1). However, at later syncytial stages 
(NC 13-14A) the percent rescue was dramatically reduced (23%) and after the onset 
of cellularization none of the injected embryos developed Filzkorper. Sprenger 
and Niisslein-Volhard (1992) observed a similar age dependent rescue of torso 
mutant embryos after the injection of torso mRNA. This experiment indicates that 
the optimal period of activation and signal transduction by D-raf in the Tor 
pathway is between NC 4 and 12. 
Temporal Control of Zygotic D-raf Expression 
Phenotypic analyses have shown that a paternally inherited wild-type D-raf 
gene does not contribute to Tor-mediated signal transduction (Perrimon et al., 
1985; Ambrosio et al., 1989). We used the D-raf allele to characterize the 
accumvdation of paternally encoded D-raf protein. This is a hypomorphic allele of 
D-raf, and sequence data suggests that this form of the gene encodes a 75 kDa D-
raf protein (Melnicket al., 1993). Embryos from D-ra/'®26 germlines were collected 
at 0-2 and 2-4 hours after egg laying, lysates were prepared and then D-rafP®26 
proteins were detected by immunoblot analysis. These embryonic lysates were 
compared to those obtained from wild-type germlines. As shown in Figure lA a 
truncated approximately 75 kDa D-raf protein was observed in embryos from D-
rfl/P®26 germlines while for wild-type embryos a 90 kDa D-raf protein was 
observed (Figure lA). 
Next, males carrying D-ra/'®^^ on their X-chromosome and a duplication 
{Dp(l;Y)zv^303) of the wild-type D-raf gene on their Y-chromosome (see Lindsley 
and Zimm, 1992) were mated to wild-type females. Then embryos were collected 
in one hour intervals and assayed for the presence of the paternal D-rafP®26 protein 
by immunoblot analysis. As shown in Figure IB, the accumulation of D-rafP®26 
proteins was observed at 2-3 hours after fertilization (NC 13 - blastoderm stages). 
Since optimal rescue of the Tor pathway by injection of D-ra/mRNA was observed 
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until NC 12, this finding is in agreement with phenotypic analyses that indicate 
there is no paternal D-raf contribution to the Tor pathway. 
Signal Transduction in the Torso Pathway is Influenced by Maternal D-raf Pools 
To determine whether rescue of posterior pattern is influenced by endogenous 
pools of norifunctional maternal D-raf protein, D-raf^'^ mRNA was injected into 
embryos from homozygous D-raf^^^^^ and D-raf^^^^ germlines. Based upon 
sequence characterization by Melruck et al., (1993) nonfunctional maternal D-raf 
protein should accumulate in embryos with these genetic backgrounds. To 
confirm this prediction, embryos from and D-raj^^^^ germlines were 
collected at 0-2 and 2-4 hours after egg laying, lysates were prepared and then D-
raf mutant proteins were detected by immunoblot analysis. These embryonic 
lysates were compared to those obtained from wild-type and germlines. 
As shown in Figure 2, a 90 kDa D-raf protein accumulates in wild-type and in 
embryos from D-raf^^^^^ and D-raf^^^ mutant germlines, but is missing from D-
rafi^-23 derived embryos. As shown in Table 2, after injection of D-raf^ mRNA 
neither D-raf^^^^^ nor D-raf^^^ germline embryos developed Filzkorper, although 
86% rescue was obtained for embryos that lack maternal D-raf protein (Table 2). 
Thus, nonfunctional maternal D-raf protein exhibits a dominant negative effect and 
inhibits rescue by D-raf^ mRNA injection. 
Recently, we have shown that three modifications of D-raf result in 
constitutive. Tor independent D-raf activity (Baek et al.. Submitted). We tested 
whether these modified versions of D-raf would suppress the dominant negative 
effect of the maternal D-raf^OOBS and D-raf^2:2 proteins (Table 2). D-rafto'^^^^l^ ig a 
membrane targeted D-raf protein and contains the signal sequence, extracellular 
and transmembrane domains of the Tor protein fused to a deleted D-raf that is 
missing amino acids 1-370. For D-rafS388A serine phosphorylation site 388, which 
is conserved in all Raf family members (Morrison et al., 1993), is substituted with 
an alanine. D-raf^445 jg missing amino acids 1-445 and encodes or\ly the C-
terminal serine/threonine kinase domain (CR3) of D-raf. 
The results of this analysis are listed in Table 2. The dominant negative effects 
of endogenous D-raf^OOBS and D-rafC2Z2 proteins were suppressed and posterior 
rescue was achieved by injection of D-rfl/o''402l mRNA. However, for injection 
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with mRNA, suppression of only the D-raf^00B8 effect was observed. 
Rescue was not achieved in either maternal background after injection of D-raf^'^^ 
mRNA. Figure 3A shows the cuticular pattern of a wild-type embryo after 
completion of embryonic development. In contrast, a non-rescued D-raf^00B8 
derived embryo is shown in Figvure 3B after injection of D-raf^ mRNA. Both head 
and tail structures are missing. However, rescue of posterior pattern including 
Filzkorper was observed (Figure 3C) after injection of D-niyS388A mRNA. 
Characterization of Other Maternal Effect Alleles of D-raf 
Since embryos from D-raf^^^^^ and D-raf^^^^ germlines were not rescued by 
injection of D-raf^^ mRNA, six additional alleles of D-raf were characterized by 
D-raf^^ mRNA injection (Table 3). At least 68% rescue was achieved for each of 
these mutant backgrounds with the exception of D-raf and D-raP^^^, showing 
37% and 45% rescue, respectively. Rescue of posterior pattern was also observed 
in all cases after injection of D-raJ^^^^ and D-raf^'^^^ mRNAs. In general, the % 
rescue was slightly higher after injection of D-rflyS388A mRNA, as compared with 
either D-raf^^ or mRNAs. Next, we characterized the accimiulation of 
D-raf protein in embryos from these D-ra/mutant germlines. As shown in Figure 
4, a 90 kDa D-raf protein is observed in wild-type embryos, and in embryos from 
homozygous D-raf and D-raP^^^^ germlines. Thus, there is a correlation 
between the presence of mutant maternal D-raf protein and the lower level of 
rescue by D-raf^^ mRNA injection. In the case of D-rfl/^C8l7^ approximately 82 
kDa truncated D-raf protein is observed, while all remaining D-raf maternal 
backgrounds including D-raf^^''^ (Figure 4D) lacked D-raf protein. 
DISCUSSION 
Temporal and Spatial Expression of D-raf 
The establishment of temporally and spatially restricted patterns of gene 
expression is a mechanism utilized during development to achieve specificity of 
cell type. In the early Drosophila embryo the maternal D-raf gene product 
participates in a signal transduction pathway mediated by Tor RTK for 
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specification of cellular fates at the embryonic poles. Positive regulation of this 
pathway is required for expression of tailless and huckebein genes to direct 
formation of head and tail structures. D-raf is also utilized in other cell types at 
later stages of development to propagate signals generated by the seveiUess RTK 
for determination of the R7 photoreceptor (Dickson et al., 1992) and the DER 
{Drosophila EGF Receptor) pathway for establishment of dorsal/ventral polarity in 
follicle cells of egg chambers (Brand and Perrimon, 1994). Thus, temporal 
regulation of D-raf s activity is related to its specific cellular ftmction. We find that 
the optimal period of activation and signal transduction by D-raf in the Tor 
pathway is between NC 4 and 12. We also show that expression of paternally 
inherited D-ra/begins between NC 13 and blastoderm stages of development and 
does not contribute to Tor signaling. 
Dominant Negative Effects of Endogenous Nonfunctional D-raf 
How D-Raf's activity is regulated in Drosophila development is not well 
understood at this time. However, based upon biochemical and distribution 
studies of the Raf family of serine/threonine kinases, localization, activation and 
substrate accessibility are important factors when considering the regulation of 
their biological function. Here, a genetic approach is utilized to investigate the 
mechanism(s) that regulate signal transduction by D-raf. Using mutatioris that 
block the pathway at specific points we hope to dissect the molecular steps 
required for propagation of the Tor signal by D-raf. In previous studies, the 
maternal defects associated with lack of D-raf protein were rescued by 
microinjection of wild-type D-raf mRNA (Baek and Ambrosio, 1994; Baek et al.. 
Submitted). 
To test whether rescue of posterior pattern is influenced by endogenous pools 
of nonfunctional maternal D-raf protein, D-raf^^ mRNA was injected into 
embryos from homozygous D-raf^^^^^ and D-raf^^^^ germlines. Phenotypically, 
embryos from these two genetic backgrounds have the same terminal deletions as 
those from D-raf^^'^^ germline clones. Pattern elements posterior to abdominal 
segments 6 or 7 are deleted and anteriorly, a portion of the cephalopharyngeal 
skeleton, the labial sense organ, and the medial tooth are missing (Ambrosio et al., 
1989). Based upon sequence characterization by Melnick et al. (1993), kinase 
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defective maternal D-raf proteins should accumulate in these embryos. Using 
Western blot analysis of lysates from these embryos, we show that a 90 kDa D-raf 
proteirxs accumulate in each of these genetic backgrounds. Wild-type levels of D-
raf protein were present for D-raf^^^^ and D-raj^^^ germline embryos. However, 
rescue was not observed after injection of D-raf^ mRNA. Thus, both D-raf^OOBS 
and D-rafC2Z2 proteins showed dominant negative effects. Based upon the 
interpretation of similar effects of kinase defective Raf-1 in vertebrates (Kolch et al., 
1991; Bruder et al., 1992; Fabian et al., 1993; MacNicol et al., 1993), it is likely that a 
factor required for wild-type D-raf activation is sequestered by the mutant D-
raf^OOBS and D-raf^^2 proteins. 
Mutation ofD-raf^^^^ and D-ra/^2Z2 
Then, how does each mutation in the D-raf^^OBS and D-rafC2Z2 proteins affect 
their activity? It has been predicted that these proteins are kinase defective based 
upon sequence characterization and the structure of cAMP-dependent protein 
kinase as a model (Meliuck et al., 1993). In general, Mg2+ATP and substrate 
binding take place within the cleft formed between the small and large lobes of a 
kinase (Taylor et al., 1992). The glycine rich nucleotide binding motif existing in all 
kinases lies within the small lobe and is responsible for association of Mg2+ATP 
with Lys 72 and Glu 91 of the large domain. The amides of these glycines have an 
access to and a hydrogen bond with the non-transferable fi-phosphates of ATP. In 
this way the glycine loop serves as a clamp that helps to lock the non-transferable 
fi-phosphate into place, together with Lys 72 and Glu 91, and the hydrophobic 
pocket that binds the adenine ring provides a docking site for Mg^+ATP. Once the 
nucleotide is bound, the glycine loop can clamp it firnUy into its proper position 
(Taylor et al., 1992). 
Using cAMP-dependent protein kinase as a model, we expect that these three 
glycines play an important role in D-raf nucleotide binding. The D-ra^^OOBS 
mutation results in the substitution of an arginine for the third glycine of the Gly-
X-Gly-X-X-Gly nucleotide binding motif. The D-ra/^2Z2 mutation results in the 
substitution Glu^l^ to valine (Melnick et al., 1993). Glu^l^ is on the edge of an 
alpha helix in the small lobe of the kinase domain. It is analogous to Glu^^ of 
cAMP-dependent protein kinase that together with Lys72 and Aspl84 are 
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important for Mg2+ATP binding and are in close proximity. It is possible that both 
mutant D-raf^®®®® and D-raf^2Z2 proteins interact with upstream factors. 
However, it remains vmclear whether either will bind and/or release substrate(s). 
Based upon the results that catalytically inactive Raf-1 can associate with Ras, 14-3-
3, and MEK (Finney et al., 1993; Freed et al., 1994; Hallenberg et al., 1994; Stokoe et 
al., 1994), we suggest that mutant D-raf proteins may form inactive protein 
complexes upon activation of Tor signaling pathway so that wild-type D-raf 
proteins translated from injected wild-type D-raf mRNA in these backgrounds 
cannot function. 
Suppression of the Dominant Negative Effects 
Next, we tested for suppression of the dominant negative effects of the 
maternal D-raf^^^BS and D_j.afC2Z2 proteins by injection of mRNAs encoding 
constitutive forms of D-raf. Thus, for these mutant D-raf proteirts, activation is no 
longer required but proper localization and substrate(s) accessibility must be 
considered to achieve the biological function. Both dominant effects were 
suppressed by the membrane targeted D-raf. However, a similar N-terminal 
deleted D-raf that lacks the membrane localization signal did not suppress these 
effects. In addition, we found that D-raf lacking serine at phosphorylation site 
S388 suppressed the dominant negative effect of D-raf^^O®® proteins but not D-
rafC2Z2 proteins. D-rafS388A js a full length D-raf and contains the entire N-
terminal regulatory region including the putative D-rasl binding domain and a 
conserved cysteine motif (CRl). These portions of the molecule are absent in the 
truncated D-raf protein. 
Since membrane targeted D-raf suppresses dominant negative effects, this 
indicates that the localization to the membrane allows D-raf accessibility to its 
substrate(s). Full length activated D-rafS388A ^jgo has access to its substrate(s) in 
the D-raf^00B8 background, while truncated D-raf does not. Apparently, the N-
terminal domain of D-raf is required for substrate access after the pathway has 
been activated, since the access to substrate by the N-terminal region is blocked. 
This result is in contrast to that shown in the absence of Tor activation for trunk 
mutant embryos that N-terminal deleted forms of D-raf have access to and can 
activate downstream target(s) at the posterior pole. 
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It is likely that proper localization, activation, and access to substrates are 
reqiiired for wild-type D-raf function. In embryos where Tor RTK is inactive, at 
the poles, all three constitutive forms of D-raf are likely localized and have access 
to their substrates. In embryos where Tor has been activated but which lack D-raf 
proteins, these three forms of D-raf can also transmit the signal, suggesting that 
they become properly localized and have access to their substrates. However, 
when a mutant form of D-raf is present, wild-type D-raf cannot rescue presumably 
due to the lack of a positive activator and/or substrate(s) that have been 
sequestered by the mutant protein. However, membrane targeted D-raf rescues, 
suggesting that it is localized properly and has access to its substrates. However, it 
is likely that the N-terminal deleted form of D-raf is not localized at the membrane 
nor does it have access to its substrate(s). D-rafS388A has an access to substrate(s) 
and is in the right location in embryos, but not embryos. 
Ras/Raf/MEK Multiprotein Complex 
Ras and Raf interact when ras is boimd to GTP (Moodie et al., 1993; Vojtek et 
al., 1993). It has been shown that Ras interacts with the N-terminus of Raf (Warne 
et al, 1993; Zhang et al. 1993; Pumiglia et al., 1995). Van Aelst et al. (1993) showed 
that the catalytic activity of Raf is not required for interaction with Ras. It has been 
reported that wild-type Raf interacts with MEK and activates it (Dent et al., 1992; 
Kyriakis et al., 1992; Macdonald et al., 1993; Jelinek et al., 1994). MEK interacts 
with the C-terminus of Raf, but does not interact with a Raf ATP binding mutant. 
Also they found that Ras/Raf/MEK interacted and formed a ternary complex 
(Huang et al., 1993; Moodie et al., 1993; Van Aelst et al., 1993). Based upon these 
studies we predict that D-rafC2Z2 does not bind ATP nor D-MEK, but will bind 
activated Ras. On the other hand, D-raf^00B8 binds activated Ras and potentially 
will also bind ATP weakly in the correct orientation. These D-raf molecules would 
then be able to interact with D-MEK. It has been suggested the active form of Raf-1 
associates with MEK and also associates with activated Ras to form a signaling 
complex (Moodie et al., 1994). We postulate that D-raf acts as a bridge and is 
necessary to lirJc D-MEK to the membrane. 
Constitutively active forms of D-raf do not require activation by the Tor RTK. 
Therefore, localization and access to substrates are key factors that may limit the 
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function of constitutively active forms of D-raf. It is likely that D-rafS388A ig 
localized and has a high affinity and access to its substrate(s) in the case of the D-
raf^OOBS background. In the case of the D-rafC222 background, D-rafS388A jg 
localized, but does not access to its substrate(s) to transfer the signal. This suggests 
that D-raf^2Z2 proteins occupy a site for D-raf s interaction with its substrate(s), 
while this site of action becomes available to D-rafS388Ain D-raf^00B8 background. 
In the case of N-terminal deleted form of D-raf, it is likely that it may not be able to 
find D-MEK due to the lack of an N-terminal end that is responsible for targeting 
D-raf to the membrane. 
Multiprotein Complex Formation for Signal Transduction 
In Saccharomyces cerevisiae, mating requires activation of a protein kinase 
cascade that includes MEJCK, MEK, and MAPK (Errede and Levin, 1993). These 
three kinases (STEll, STE7 and FUS3 or KSSl) are associated together in a single 
complex that is tethered by the Ste5 gene product (Choi et al., 1994). Therefore, 
STE5 serves as a protein kinase linker. This association is independent of catalytic 
activity, suggesting that the complex may form prior to signal transduction. 
Therefore, it is possible that the ternary complex of Ras/Raf/ MEK/MAPK can be 
formed to transduce the signal for the MAPK cascade in Drosophila, C. elegans, 
Xenopus, and mammalians and also similar types of regulation for this complex 
may exist. 
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Table 1. Rescue of D-raj^^-^^ mutant embryos by wild-type D-ra/mRNA: 
Time dependence 
Number of Number of Rescue of Percent 
Stages injected embryos with Filzkorper rescue 
embryos cuticles* 
Cleavage 26 12 10 83 % 
Pole cell 
formation 16 8 6 75 % 
Late syncytial 
blastoderm 21 13 3 23 % 
Cellular 
blastoderm 20 10 0 0 % 
* The male embryos from D-raf mutant germlines do not develop cuticles (Materials and 
Methods). 
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Table 2. Microinjection of different D-raf mRNAs into D-ra/mutant embryos. 
Maternal D-raf Number of Number of Rescue of Percent 
genotypes mRNA injected embryos with Filzkorper rescue 
embryos cuticles* 
D-raf^ -29 D-rafWT 
D-raf^®®^ 
D-rafA445 
D-raftor4021 
455 
270 
320 
156 
213 
145 
190 
73 
184 
112 
181 
58 
86% 
77% 
95% 
80% 
O.j-af^OOBS D-raf^ 
D-raf^®^^ 
D-rafA445 
D.].aftor4021 
171 
263 
236 
194 
66 
141 
106 
78 
0 
98 
0 
54 
0 %  
70% 
0 %  
69% 
D-ra/C2Z2 D-rafWT 
D-raf^^®^ 
D-rafA445 
D-rafto''402l 
174 
175 
173 
225 
45 
46 
55 
33 
0 
0 
0 
18 
0 %  
0 %  
0 %  
55% 
* The male embryos from D-raf mutant germlines do not develop cuticles (Materials and 
Mefliods). 
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Table 3. Microinjection of different D-raf mRNAs into D-m/mutant embryos. 
Maternal 
genotypes 
D-raf Number of Nimiber of Rescue of Percent 
mRNA injected embryos with Filzkorper rescue 
embryos cuticles* 
D-raf0 D-rafWT 
D-raf^^^ 
D-rafA445 
156 
116 
130 
50 
20 
24 
34 
16 
7 
68% 
80% 
29% 
D-raf«ft D-rafWT 
D-raf^®®^ 
D-rafA445 
168 
133 
144 
63 
49 
64 
23 
10 
13 
37% 
20% 
20% 
D-rapf303 D-rafWT 180 
D-rafS388A 117 
D-raf^445 243 
65 
55 
79 
29 
29 
4 
45% 
53% 
5% 
D-raf^07w D-rafWT 
D-raf^^®^ 
D-rafA445 
141 
127 
168 
63 
65 
119 
57 
58 
114 
91% 
89% 
96% 
D-raf^75 D-rafWT 150 
D-rafS388A 117 
D-raf^445 164 
83 
47 
100 
63 
42 
80 
76% 
89% 
80% 
D-rapC817 D-rafWT 119 
D-rafS388A 149 
D-rafA445 152 
55 
88 
85 
47 
76 
54 
86% 
86% 
64% 
* The male embryos from D-raf mutant germlines do not develop cuticles (Materials and 
Methods). 
Figure 1. Expression of D-raf proteins during development. After collected 
embryos were processed, D-raf immunoprecipitation from embryonic extracts 
was performed. Then they were resolved by SDS-PAGE (7.5 % polyacrylamide 
gel) and examined by immunoblotting using a D-raf specific antibody. (A) 
Maternal expression; Accumulations of 90 kDa D-raf protein in wild-type 
embryos and 75 kDa D-raf protein in embryos generated from homozygous D-
raf^26 germline females. (B) Zygotic expression; Accumulation of 75 kDa D-raf 
protein in embryos produced by females carrying heterozygous D-raf^/D-
rafPB26 on their X-chromosome is shown. 
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Figure 2. Western blot analysis. Accumulation of D-raf proteins in embryos 
produced by different D-ra/germline clones. (A) wild-type (B) D-raf 11*29 (C) I> 
raf400B8^ and (D) D-raf^2:2. 
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Figure 3. Inductiori of terminal structures in embryos after injection 
of D-raf mRNA. Cuticular preparations of embryos are shown after the 
completion of embryoruc development. (A) A wild-type embryo from a wild-
type mother with Filzkorper (arrow). (B) An embryo from a homozygous D-
rafOOBS germline female after injection of wild-type D-ra/mRNA showing no 
rescue of posterior terminal structures. (C) An embryo from a homozygous D-
r(ij400B8 germline female after injection of D-ni/S38SA mRNA showing rescue of 
posterior terminal structures including Filzkorper (arrow). 
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Figure 4. Western blot analysis. Accumulation of D-raf proteins in embryos 
produced by different D-raf germline clones. (A) wild-type, (B) (C) D-
rafDF903^ (D) D-rafEA75^ and (E) D-raf^817, 
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GENERAL SUMMARY AND CONCLUSIONS 
The activation of Torso receptor tyrosine kinase (RTK) and subsequent events 
in the signal transduction pathway are required for development of terminal 
structures in Drosophila embryos. This pathway relies on the action of maternal 
products to specify cell fates at the embryonic poles. D-raf, one of maternal 
products, transmits the Torso (Tor) signal generated at the embryonic poles for the 
specification of head and tail structures of the embryo. 
It has been shown in vitro that D-raf has the ability to autophosphorylate when 
incubated with Mn2+ and p2p] ATP. Phosphoamino acid analysis has revealed that 
there are phosphoserine and phosphothreonine residues in D-raf after 
autophosphorylation, indicating that D-raf has intririsic serine/threonine kinase 
activity (Sprenger et al., 1993). Thus, as a serine/threonine kinase we predict that 
the kinase activity of D-raf plays an essential role in transmission of the terrmnal 
signal. By microinjecting either wild-type D-raf mRNA or kinase defective D-raf 
mRNA into embryos lacking maternal D-raf proteins, we demonstrate that the 
serine/threonine kinase activity of D-raf is required for the Tor signal transduction 
pathway and the human Raf-1 kinase can substitute for D-raf kinase in this 
pathway. 
Regulation of D-raf Serine/Threonine Kinase 
Recently, it has been shown that maternal D-raf becomes phosphorylated two 
hours after fertilization in wild-type embryos. At this time the Torso RTK has been 
activated (Sprenger et al., 1993). Furthermore, using phosphopeptide analysis 
phosphorylation sites in Raf-1 have been mapped (Morrison et al., 1993). In this 
study, conservation of serine phosphorylation sites was observed between D-raf 
and mammalian Raf-1 kinases. These findings indicate that the phosphorylation of 
conserved serine residues is likely an important regulatory mecharusm utilized by 
the Raf family of serine/threonine kinases. Since it has been shown that D-raf has 
serine/threonine kinase activity, it will be important to find pivotal 
phosphorylation sites critical for the regulation of its function as a kinase. We find 
that the serine or its phosphorylation at amino acid 743 is essential for D-raf 
function in the terminal class pathway, but serine or its phosphorylation at amino 
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acid 388 is not required for D-raf to transmit the Tor signal. Rather, D-raf^®8A jg 
shown to be constitutively active and rescues the terminal defect in trunk mutant 
embryos in which the Tor receptors are not activated. 
The D-raf protein kinase consists of 3 domains: the kiiiase domain is referred to 
as CR3; the serine/threonine rich domain, CR2; and the cysteine containing motif, 
CRl (Rapp et al., 1988). There is evidence that the amino terminal portion of the 
protein containing the CRl and CR2 domains acts to regvdate the Raf-1 molecule in 
mammalian cells. Removal of CRl and/or CR2 gives rise to an activated Raf-1 
molecule (Heidecker et al., 1990; Bruder et al., 1992). Two different truncated 
forms of D-raf (D-raf^3l5 and D-raf^^^) are able to rescue the terminal defect in 
embryos lacking maternal D-raf proteins. This indicates that truncated forms of D-
raf in the absence of wild-type D-raf molecules can properly identify its 
substrate(s) and act to transmit the terminal signal. 
Targeting of Raf-1 to the membrane results in a Ras independent, active form of 
the Raf-1 kinase (Leevers et al., 1994; Stokoe et al., 1994). The membrane targeted 
form of D-raf not only rescues the terminal defect but suppresses abdominal 
segmentation. Thus, the membrane associated form of D-raf (D-raftor402l)^ 
truncated forms of D-raf, has an access to its substrate(s) and effectively transmits 
the Tor signal at the posterior pole. 
Sprenger and Niisslein-Volhard (1992) showed that the activation of Tor in the 
middle of embryos suppresses the normal segmented pattern and promotes 
ectopic formation of terminal structures. We demonstrate that D-raf^o^'^o^l^ but not 
D-rafS388A or D-raf^^^^^ induces the suppression of abdominal segmentation and 
development of ectopic Filzkorper in the middle. Thus, in the middle of the 
embryo where Tor is not activated, only membrane targeted D-raf promotes 
terminal development. It is possible that an additional requirement exists for D-raf 
signaling in the central domain and as a consequence of its membrane localization 
and amino-terminal trimcated sequences, D-raf^o'^^^l ig competent to promote Tor 
signal transduction within this region. In mammalian ceUs RTK activation leads to 
the formation of Ras/Raf-1 complexes at the membrane and this facilitates efficient 
activation of Raf-1 (Leevers et al., 1994; Stokoe et al., 1994). It has also been 
demorrstrated that Ras, Raf-1, and MEK can form a ternary complex (Jelinek et al., 
1994). If D-raf membrane association is required for its biological activity, then it is 
likely that within the central domain of a Drosophila embryo activation of Tor 
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and/or D-rasl results in the recruitment of D-raf to the membrane by its 
interaction with D-rasl. Therefore, we postulate that two requirements for D-raf 
function are necessary; (1) membrane association of D-raf is essential for its 
biological function in Tor signal transduction, (2) at the embryonic poles there is a 
D-raf localizing activity by a "docking protein(s)", that act independent of Tor 
activation, and (3) this docking protein(s) is absent from the central domain of the 
embryo. 
Interaction between D-raf and Its Activator(s) and Substrate(s) 
It has been postulated that the kinase defective Raf-1 competes with 
endogenous wild-type Raf-1 for a limiting amount of urudentified positive 
activator (MacNicol et al., 1993). Indeed, endogenous pools of nonfunctional 
maternal D-raf protein (D-raf^OOBS and D-raf^2;2) inhibits the rescue of terminal 
defects by D-raf^ mRNA, indicating that nonfunctional maternal D-raf protein 
exhibits a dominant negative effect. This suggests that wild-type D-raf requires an 
activator that has been sequestered by the maternal mutant D-raf protein. 
Accumulation of D-raf protein 
We characterized the accumulation of D-raf protein in embryos at 0-2 and 2-4 
hours after egg laying, from D-raf mutant germlines. A 90 kDa D-raf protein is 
detected in wild-type embryos, and those derived from D-rafiOOB8^ D.rafClZl^ d. 
rafDF903^ and D-rafbut is absent from D-raf^^-^^,D-raf^^^^, D-raf^^^, and D-raffl 
germlines. Truncated forms of D-raf accumulate in embryos from D-raf and D-
rafDC817 germlines. Thus, there is a correlation between the presence of mutant 
maternal D-raf protein and the lower lever of rescue by D-raf^ mRNA injection. 
Temporal Regulation of D-raf 
The activation of D-raf is required for the expression of the zygotic genes tailless 
and huckebein (Pignoni et al., 1992). The earliest expression of tailless can be 
detected at nuclear cycle 11 shortly after pole cell formation (Pignoni et al., 1990, 
1992). This indicates that the terminal system is active prior to or at this stage. By 
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microinjecting wild-type D-raf mRNA into embryos from germline 
clones at different developmental stages, we find that the temporal control of D-raf 
activation takes place between nuclear cycle 4 and 12. We also detect that the 
zygotic expression of the D-raf gene occurs at nuclear cycle 13,14, and blastoderm 
stages, indicating that the paternal D-raf protein is not involved in Tor signaling. 
Conclusion 
These results provide some insights toward vmderstanding the mecharusm and 
regulation of signal transduction processes in Drosophila. It has been shown that 
several biochemical pathways that function to elicit a developmental and/or 
mitotic response in mammalian and insect cells require structurally related 
proteins. Thus, conclusions that are drawn from these studies will not only 
elucidate the role of D-raf in Drosophila development, but may also provide clues 
toward understanding the roles played by wild-type and oncogenic Raf-1 in 
mammalian cells. 
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